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Abstract 
 
Native vascular tissue functions are highly dependent on structural organization 
at the super-cellular, cellular, and sub-cellular spatial scales. We hypothesized that the 
structure-function relationship of vascular tissues in vivo can be leveraged to engineer 
vascular tissues in vitro by prescribing the shape of constituent cells and their assembly 
into organized three-dimensional structures. To this end, we first asked if vascular 
smooth muscle cell shape influences cellular contractility. We engineered human 
vascular smooth muscle cells to assume similar shapes to those in elastic and muscular 
arteries and then measured their contraction while stimulating with endothelin-1. We 
found that vascular smooth muscle cells with elongated shapes exhibited lower 
contractile strength but a greater percentage increase in contraction after endothelin-1 
stimulation, suggesting that elongated vascular smooth muscle cell shape endows the 
muscular artery with greater dynamic contractile range. Next, we sought to assemble cells 
into tissues by employing a three-dimensional cellular patterning strategy based on the 
folding of porous, thin polymer films. We assembled different three-dimensional 
endothelial and vascular smooth muscle organizations by patterning two-dimensional 
poly(lactic-co-glycolic) acid and collagen thin films with cell suspensions at prescribed 
locations. The films were subsequently folded following Miura-ori geometry guidelines 
and the matrices were embedded subcutaneously in immunodeficient mice in order to 
assess the vascularization of the implanted constructs. We found that spatial organization iv 
 
that allowed endothelial and vascular smooth muscle cells to interact adjacent to each 
other laterally in the same folding plane created the densest vascularized network, 
suggesting that three-dimensional structural organization of vascular cells can influence 
the formation of vascularized networks. Taken together, our result shows that functional 
vascular tissues in vitro can be engineered by encoding structure cues in their design and 
assembly.       
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1  Introduction 
Engineering functional vascular smooth muscles in vitro remains challenging 
because of the complexity of recapitulating structural organization across multiple spatial 
scales. Early efforts primarily focused on controlling vascular smooth muscle functions 
by biochemical signaling; however, accumulating evidence suggests that 
mechanotransduction, the process by which cells convert mechanical stimuli in the 
cellular microenvironment into biochemical cues, holds promise as a novel approach to 
engineering this tissue. Here, we discuss an engineering strategy that recapitulates 
mechanotransduction to build functional vascular smooth muscles in vitro. By harnessing 
mechanical cues in the cellular microenvironment, functional vascular smooth muscles 
can be engineered with cytoskeletal architecture. A number of vascular smooth muscle 
functions that depend on the cytoskeletal architecture could then be evaluated through 
performance metrics to assess if desired functional outcome is achieved. Engineering 
functional vascular smooth muscle in vitro may yield new insight on the development of 
vascular grafts and accelerate drug discovery research for treating cardiovascular diseases. 
 
1.1  Mechanotransduction as a Strategy for Engineering Functional Vascular 
Smooth Muscle 
Engineering functional vascular tissue in vitro is not a trivial pursuit due to the 
dependency of vascular functions on the three-dimensional structural hierarchy that spans 
several orders of spatial magnitude ranging from centimeter length scale of the arteries to 
the nanometer length scale of cytoskeletal proteins (Figure 1-1). For example in a healthy 
arterial tissue, endothelial cells (ECs) line the inner most layer of the blood vessel to 2 
 
protect the vascular smooth muscles (VSM) from blood shearing force. In turn, the VSM 
provides structural support to the ECs by wrapping around the ECs in helices to 
Engineering functional vascular smooth muscles (VSMs) in vitro remains challenging 
because VSM structure and function interact over several orders of spatial magnitude, 
ranging from the centimeter-length scale of arteries to the nanometer-length scale of 
cytoskeletal proteins (Figure 1). VSM structure and function are maintained in vivo in 
several ways, one of which is the regulation of mechanical forces at the tissue, cellular, 
and sub-cellular spatial scales through a process called mechanotransduction, in which 
cells translate mechanical stimuli into biochemical reactions. In the native environment, 
cyclic cardiac cycles expose VSM to mechanical stimuli from a number of sources, such 
as transmural pressure, vascular strain induced by pulsatile pressure, and circumferential 
and axial wall tension [1]. VSM, in turn, responds by inducing changes in cytoskeletal 
organization [2-4], membrane ionic conductance [5-7], and signaling activation [8-11], 
that lead to functional changes in VSM contraction, secretion, growth, and migration. A 
well-studied example of this process is the myogenic response, where small arteries 
contract to counteract increased intraluminal pressure, protecting the blood vessel from 
potential hypertensive injury [12]. Thus, mechanotransduction enables VSM to respond 
to mechanical stimuli encoded in the local microenvironment and remodel its function to 
serve the needs of the blood vessel.  
 3 
 
 
Figure 1-1: Hierarchical organization of vascular tissue spans multiple spatial scales 
from nanometers to meters. Vascular smooth muscle cells assemble into muscle tissue 
that forms the media layer of the elastic and muscular arteries. The spindle shaped cells 
contains nanometer scaled protein complexes that allow it to respond to mechanical cues 
in the cellular microenvironment. Adapter in part from Servier Medical Art.  
 4 
 
Differentiated, healthy VSM typically operate in sustained constriction, or tone, 
to regulate peripheral resistance, thereby maintaining systemic blood pressure and 
controlling organ blood flow. Disruption of tone can produce vascular disorders such as 
hypertension [13] and vasospasm [14], where VSM contraction deviates from its 
homeostatic equilibrium. Such conditions are commonly treated by pharmacological 
manipulation of VSM contractile signaling to modulate its tone. Traditional drugs that 
target the VSM contractile pathway include alpha- and beta-adrenergic receptor 
antagonists, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, 
and angiotensin II receptor antagonists [15]. Drug development efforts now seek to 
identify compounds that either activate or inhibit VSM cell (VSMC) large conductance 
Ca2+ activated K+ (BKCa) channels to regulate the membrane potential of VSM and, in 
turn, control the vascular tone [16]. The efficacy of these drugs on VSM tone can only be 
validated in vitro if a VSM model functionally recapitulates its in vivo counterpart. 
In this review, we discuss how an engineering algorithm based on recapitulating 
the native mechanotransduction processes can be applied to design, build, and test a 
functional VSM in vitro model. We first demonstrate that cytoskeletal proteins in the 
extracellular, intercellular, and intracellular domains are mechanotransductive 
components responsible for regulating VSMC architecture and functions. We then 
describe the mechanical cues that can be used to design the assembly of these 
cytoskeletal proteins into VSM with engineered cellular architecture. Finally, we present 
a performance evaluation metric comprising functions that could be influenced by the 
engineered cellular architecture.   
 5 
 
1.2  Cytoskeleton Components in Vascular Smooth Muscle Cell 
Mechanotransduction 
VSMCs sense a wide array of mechanical stimuli through a network of 
cytoskeletal proteins embedded in the extracellular, intercellular, and intracellular 
domains. These dynamic proteins continuously sense changes in the cellular 
microenvironment and remodel their organization to drive the force balance towards 
equilibrium (Figure 1-2). For example, integrin proteins are directly connected to actin 
filaments, allowing forces to be transmitted from outside to inside the cells [17]. 
Cadherin junctions directly couple adjacent VSMCs together and propagate mechanical 
signals from one cell to the next [18]. Actin, intermediate filaments, and microtubules 
propagate mechanical signals through common hubs at dense plaques throughout the 
VSMC cytoplasm [19]. Thus, the cytoskeletal proteins provide design parameters that we 
can engineer to recapitulate the mechanotransduction processes in VSMC.  6 
 
   
 
 
Figure 1-2: Mechanotransductive cytoskeletal proteins in vascular smooth muscle 
cells. Integrin links the ECM protein such as collagen to actin fibers, allowing 
extracellular mechanical signals to be directly transmitted into the cell. Actin responds to 
mechanical input to the cells by rapid by changing the F- to G-actin ratios and acts as an 
intracellular sensor. Cadherin junctions provide mechanical links between adjacent cells, 
allowing forces to be transmitted between cells. 
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1.2.1  Mechanical Signaling through Integrin-ECM Interface 
Integrin proteins are transmembrane, heterodimeric receptors comprising α- and 
β-subunits. They connect the extracellular matrix (ECM) to the internal cytoskeletons at 
the site of focal adhesion complex via the short cytoplasmic tail of the β-subunit (Figure 
1-3). Furthermore, integrins transduce both “outside-in” and “inside-out” mechanical 
signals in many different cell types. Twenty-four integrins have been described and 
among them, α1β1, α2β1, α3β1, α4β1, α5β1, α6β1, α7β1, α8β1, α9β1, αvβ1, αvβ3, αvβ5, and α6βv 
are found in VSMCs [20, 21]. 8 
 
 
Figure 1-3: Mechanotransductive proteins in the focal adhesion complex. 
Transmembrane protein integrin physically links extracellular matrix protein such as 
collagen in the extracellular domain to intracellular structure protein such as F-actin. This 
allows mechanical inputs to be transmitted in both ways, allowing “outside-in” and 
“inside-out” signaling. Cellular components are not to scale.     
In vitro studies using isolated arterioles and VSMCs have provided strong 
evidence that some integrins are crucial mechanotransductive elements for VSMCs. 
Wilson and colleagues demonstrated that soluble fibronectin, integrin binding peptide 
GRGDTP, and antibodies to β3 or αvβ5 all independently block the mitogenic response of 
newborn rat VSMCs to mechanical strain [22]. Other studies subsequently showed that 9 
 
an integrin-recognizing synthetic RGD peptide can cause sustained vasodilation [23] and 
decreased intracellular Ca2+ level in rat VSMCs [24]. These early studies demonstrated 
that integrins play an important role in transducing mechanical cues to intracellular 
signals that produce functional adaptive responses. More recently, studies on isolated rat 
arteriole tissue and VSMCs showed that antibody blocking of α5β1 and αvβ3 integrins 
significantly inhibits myogenic constriction [25, 26]. However, pulling on fibronectin and 
β1-integrin antibody-coated magnetic beads on isolated renal VSMCs elicits an increased 
cell force and sustained traction, autologous to pressure-induced myogenic response [27]. 
The integrin mechanotransduction mechanism has also been linked to BKCa ion channel 
activities and Src-dependent pathways [28, 29]. Collectively, these studies demonstrated 
that integrins are critical to mechanotransduction and adaptive remodeling in VSM tissue 
and cells.  
 
1.2.2  Mechanical Signaling through Intercellular Junctions 
In addition to cell-ECM connections, VSMCs in the vascular wall contain a 
variety of cell-cell adherent junctions, including cadherin and gap junctions [30]. The 
cadherin family of calcium-dependent transmembrane receptors is mechanically 
important: they bind together adjacent VSMCs and link them intracellularly to actin 
filaments via catenins, allowing direct force transmission between neighboring cells [31-
33].  
VSMCs express multiple cadherins, including N-cadherin, T-cadherin, R-
cadherin, cadherin-6b, and E-cadherin (in the case of atherosclerotic lesions) [21]. The 
predominant cadherin, N-cadherin, is expressed at a higher level in human venous 10 
 
smooth muscle cells (SMCs) than in arterial SMCs [34]. While N-cadherin has been 
investigated in the context of VSMC migration [35], proliferation [36], and survival [37], 
Jackson et al. showed that selective blockage of N-cadherin or a cadherin inhibitory 
peptide in rat cremaster arterioles inhibits myogenic response to pressure changes 
independent of [Ca2+]i [38], implicating N-cadherin in mechanical load sensing and 
arteriolar contraction regulation. T-cadherin was originally identified in a membrane 
fraction of aortic SMCs [39]. Unlike classical cadherin family members, T-cadherin does 
not have transmembrane and cytosolic domains but instead is anchored to membranes by 
means of glycosylphosphatidylinositol (GPI). An analysis of Triton-X fractionized 
human and rat VSMCs revealed that T-cadherin co-localizes with mechanotransducing 
signaling molecules such as Gαs protein and Src-family kinases in caveolin-rich 
membrane domains [18], suggesting that T-cadherin may function as a local signal-
transducing protein as well as an adhesion molecule. Additional studies on the exact 
mechanism of cadherin-based mechanosensing are needed to understand its role in the 
regulation of VSMC cytoskeletal structure and contractile responses.  
 
1.2.3  Intracellular Signaling Mechanics 
Actin is the most abundant cytoskeletal protein in contractile VSMCs, 
contributing ~20% of total protein content [40]. Four of the six vertebrate isoforms of 
actin are found in VSMCs: α-smooth muscle actin (SMA), β-non-muscle actin, γ-SMA, 
and γ-cytoplasmic actin. Large arteries typically contain about 60% α-SMA, 20% β-non-
muscle actin, and about 20% combined γ smooth muscle and γ non-muscle actin [41]. 
Both α- and γ-SMA are commonly referred to as contractile actin because of their 11 
 
association with myosin filaments in generating tension and cell shortening. The two 
remaining actin isoforms are referred to as cytoplasmic actin and are localized to the cell 
cortex [42].  
Although the precise role of cytoplasmic actin in arteriolar myogenic behavior 
remains uncertain, growing evidence supports the hypothesis that this subpopulation of 
actin contributes to VSMC mechanotransduction [2]. Earlier studies using 
pharmacological agents demonstrated that a short exposure period to actin 
depolymerizing agent profoundly suppresses VSM tension development [43-46], while 
exposure to actin stabilizer enhances myogenic tone [47], highlighting the critical role of 
actin polymerization in VSMC contraction and tension development. Independent studies 
using different techniques have demonstrated that actin polymerization is attributed to a 
small portion of G- to F-actin transition [47-50] that is associated with a redistribution of 
actin from the cell periphery (cortical region) to the cell interior [49]. More recently, Kim 
and colleagues, using labeled G-actin monomers, directly observed actin incorporation 
into cortical filaments upon agonist treatment [51] and that the non-muscle cytoplasmic 
actin is primarily responsible for the agonist-induced actin polymerization [40]. Given the 
known link between F-actin and putative mechanotransductive components such as 
integrins [52], cadherins [53], and ion channels [54], these results suggest that the cortical 
non-muscle actin isoforms compose a dynamic subpopulation of actin that allows it to 
function as an intracellular sensor that actively remodels its polymerization state in 
response to the level of mechanical force applied to the cells.  
Intermediate filaments form bundles and associate with dense bodies to provide 
three-dimensional integrity to VSMCs [55]. Two intermediate proteins are found in 12 
 
VSMCs, vimentin and desmin [55]. Vimentin production is high in VSMCs of large 
arteries. In human arteries, vimentin localization decreases gradually from proximal to 
distal, while desmin localization gradually increases [56-58]. Vimentin- [59] and desmin-
deficient mice [60] with normal myogenic responses display alterations in vasomotor 
properties such as agonist sensitivity and impaired flow-dependent dilation, suggesting 
that vimentin and desmin may be required for sensing mechanical cues in the local 
microenvironment. A similar dependence on vimentin occurs in airway SMCs. Wang and 
colleagues reported that down-regulation of vimentin in canine airway smooth muscle 
attenuates force generation [61], while Tang et al. showed that airway smooth muscle 
stimulated with contractile agent 5-HT undergoes spatial rearrangement [62, 63]. 
Collectively, these results suggest that intermediate filaments of vascular and airway 
SMCs are important for adaptive remodeling to mechanical cues.  
Microtubules provide resistive forces in many cell types and are considered the 
compression bearing elements [64]. Since the ability to adequately stain and detect 
polymerized microtubules in dense contractile tissue depends on the tissue type and 
staining method [65], contradicting findings on the role of microtubules in 
mechanotransduction have been reported for VSMCs. For example, one study showed 
that depolymerization of microtubules causes an elevated level of myogenic constriction 
in rat skeletal muscle arterioles when pressurized intravascularly. Furthermore, this 
response involves Rho-A dependent Ca2+ sensitization without an overt increase in [Ca2+
i] 
[66], suggesting that regulation of microtubule dynamics may be directly linked with 
VSMC contraction and reactivity. However, a higher level of isometric force is 
associated with an increased level of intracellular calcium in porcine coronary VSMCs 13 
 
when treated with microtubule depolymerizing agent [67], suggesting that microtubules 
may not directly contribute to VSMC mechanical characteristics but rely on modulation 
of Ca2+ signal transduction. While the difference may be caused by the origin and species 
of the VSMCs, further studies are needed to determine the role of microtubules in VSMC 
mechanotransduction.  
 
1.2.4  Zyxin and Nucleus as Mechanosensors 
  Focal adhesion associated protein and the nucleus also participate in VSMC 
mechanotransduction. For example, zyxin, a zinc-finger protein predominated located in 
the focal adhesions and stress fibers, dissociates from focal adhesions, translocates into 
the nucleus, and mediates expression of mechanosensitive genes within minutes of cyclic 
stretching in rat aortic SMCs [10]. Although the mechanistic interactions between zyxin 
and mechanosensitive genes remain to be elucidated, these results suggest that zyxin 
functions as a mechanosensor. The nucleus was recently found to interact directly with 
the cytoskeleton via nuclear membrane proteins such as the SUN/KASH domain proteins 
[68-70] (Figure 1-4). This physical linkage allows mechanical forces exerted on the 
surface adhesion receptors to be transmitted along the cytoskeletons to the protein 
complexes in the cytoplasm and nucleus [71]. By studying the contractile filament 
organization in airway SMCs using electron microscopy, Kuo et al. revealed that 
contractile filaments for airway SMCs are arranged parallel to the longitudinal axis and 
centrally attached to the nuclear envelope, effectively making the nucleus a force-
transmitting structure [72]. Similar findings were observed by Nagayama and colleagues 
in aortic SMCs: stress fiber stabilizes the position of intranuclear chromatin through 14 
 
mechanical connection with the nucleus [73], which modulates gene and protein 
expression in VSMCs and alters functional behavior. Taken together, these studies 
provide strong evidence that zyxin and the nucleus also play a role in VSMC 
mechanotransduction.   
 
Figure 1-4: Force transmissions via cytoskeleton to the nucleus. F-actin stress fibers 
and intermediate filaments are connected to the SUN protein dimers via the Nesprin-1/2 
and Nesprin-3 protein complexes. The SUN proteins bind to nuclear lamina and other 
nuclear envelope proteins, which are connected to DNA and chromatin inside the nucleus. 
These proteins together couple the cytoskeleton mechanically to the nucleus, allowing 
mechanical signal to directly influence chromatin remodeling.   15 
 
In summary, the extracellular, intercellular, and intracellular components of the 
VSMC cytoskeleton are embedded with proteins and filaments that are able to detect 
mechanical stimuli from the ECM, adjacent cells, or within the cytoplasm. Sensing these 
stimuli allows the cell to activate signaling pathways that promote structural remodeling 
of its cytoskeleton to offset or adapt to mechanical loading. These mechanotransductive 
cytoskeletal components serve as the design components that enabled us to build VSMC 
with engineered cytoskeletal architecture with desired functions.   
  
 
1.3  Engineering Vascular Smooth Muscle Form with Mechanical Cues 
VSMCs in their native environment experience a variety of mechanical stimuli 
such as cyclic stretching, cell shape deformations, ECM interactions, substrate stiffness, 
and surface topography at micro- and nanoscale. Due to the mechanotransductive nature 
of the cytoskeletal proteins, mechanical stimuli can regulate both cytoskeletal 
architecture and cellular function and cytoskeletal proteins are tightly regulated 
spatiotemporally to ensure proper VSMC structure and function in normal physiological 
settings. When stimuli deviate from the normal range, maladaptive remodeling occurs in 
the cytoskeletal architecture and leads to diseased function in VSMCs. For example, in 
the case of vascular aging, wear and tear from cardiac cycling causes fatigue and fracture 
in the elastic fibers, promoting degeneration of the media layer and vessel stiffening [74]. 
These changes in the ECM composition and substrate stiffness increase VSMC stiffness 
by increasing their adhesion molecule expression [75, 76] and drive the system away 
from healthy conditions and toward cardiovascular diseases.   16 
 
Although maladaptive remodeling in the VSM native environment can cause 
undesirable outcomes in vivo, we can harness the contribution of mechanotransduction on 
VSMC form and function in vitro to our advantage by regulating the assembly of these 
cytoskeletal proteins to build VSM with engineered cellular architecture. In the following 
sections, we will review the influence of different mechanical cues on the VSMC 
cytoskeletal architecture.  
 
1.3.1  Tensile Stress 
The pulsatile nature of the vasculature exposes VSMCs to cyclic stretching in 
their native environment. Using ultrasonography and other methods, direct viewing of the 
vasculature in vivo demonstrated that each cardiac cycle can deform human arteries, 
arterioles, and veins between 6 and 22%, with more distention experienced by larger, 
proximal arteries [77-80]. These observations generated interest in the effect of stretching 
on VSMC behavior in vitro. Cyclic stretching on rat VSMCs in vitro produces rapid 
reorganization of stress fibers perpendicular to the stretching direction [4]. Longitudinal 
stretching of the vascular wall induces actin polymerization [81]. In addition, cyclic 
stretching in rat VSMCs leads to increased expression level of insoluble focal adhesion 
contact components [3], paxillin, and vinculin [82], suggesting that cyclic stretching may 
strengthen the number and size of focal adhesion complexes. These findings indicate that 
mechanical stimulation in the form of cyclic stretching can remodel the state and 
organization of actin stress fibers and focal adhesions, which may subsequently feed back 
to VSMC functional changes.  
 17 
 
1.3.2  Cellular Boundary Condition 
Recent advances in cellular engineering have enabled reproducible and precise 
studies on the role of cell shape in mechanotransduction [83-85]. Our group has utilized 
microcontact printing (µCP) to micropattern ECM proteins on substrate to create user-
defined cell-adhesive patterns that produce cells with various shapes [86-89]. More 
recently, our group engineered VSM tissues of varying widths by constraining the line 
width of micropatterned fibronectin and lamina proteins [90]. We found that, while the 
alignment of F-actin stress fibers is similar, the nuclear eccentricities of constituent 
VSMCs significantly correlates with cell shape with length-to-width aspect ratios (ARs) 
between 20:1 and 50:1 [90]. To investigate the shape-contractility function more 
rigorously, we recently engineered single VSMCs on fibronectin islands with ARs from 
5:1 to 20:1 and quantified their F-actin alignment by measuring the orientational order 
parameter (OOP) and nuclear eccentricity (Figure 5). In contrast to VSM tissues, we 
found that isolated VSMCs with higher ARs have increased OOP and nuclear eccentricity, 
suggesting elongated cell shape leads to more aligned stress fibers and elongated nuclei 
[91]. 
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The effect of two- and three-dimensional (3D) VSMC shape on cytoskeletal 
remodeling has also been described by several other groups. Thakar et al. showed that 
bovine VSMCs cultured on micropatterned collagen strips with elongated cell shape have 
decreased expression of actin stress fibers and α-actin on narrower strips [92]. They also 
reported that elongated cell shape lowers the nuclear shape index of isolated VSMCs 
while reduced spreading area significantly reduces nuclear volume [93]. When isolated 
rat VSMCs were cultured on user-defined cell adhesive patterns fabricated by plasma 
lithography, Goessl and colleagues observed cell shape-dependent actin formation and 
nuclear shape change [94]. When rat VSMC volume was changed in three dimensions 
(3D) through hyperosmotic shrinkage or hyposmotic swelling, a dramatic elevation of F- 
to G-actin ratio was observed [95], suggesting that actin polymerization occurs in 
response to cell shape changes in 3D. Thus, these reports demonstrated that cellular shape 
and cytoskeletal architecture direct the location and organization of mechanosensitive 
components including stress fibers and nucleus, suggesting one potential mechanistic 
pathway in which cell shape changes in two and three dimensions are translated to 
functional differences in VSMCs. 
 
1.3.3  Extracellular Matrix Interactions 
ECM components influence VSMC phenotype and functions like migration, 
proliferation, and contraction in vitro. Concomitantly, significant changes in cytoskeletal 
organization and expression have also been reported. One early study reported that 
isolated rat VSMCs cultured on laminin develop significantly fewer focal adhesions than 
cells cultured on fibronectin [96]. Another found different amounts of myofilament 20 
 
expression in rabbit VSMCs cultured on interstitial matrix (collagen I and fibronectin), 
basal lamina protein (collagen IV and laminin), and the serum adhesion protein 
vitronectin [97]. In addition, immunofluorescent staining of stress fibers with antibodies 
against α-actin, myosin heavy chain isoform SM2, and vimentin, revealed that stress fiber 
expression of VSMC cultured on fibronectin coated substrate over a 5-day culture period 
gradually reduced with time [98], suggesting that ECM can mediate active remodeling of 
cytoskeleton. More recently, distinct morphologies of actin organization and focal 
adhesion formation were found on VSMCs cultured on different ECM components [99]. 
Specifically, for VSMCs cultured on fibronectin and collagen IV, cytoskeletal stress 
fibers organize along the long axis of the cell and tight bundles occur along the periphery; 
whereas this stress fiber organization is less typical for cells cultured on collagen I and 
laminin. In addition, rounded focal adhesions are induced by fibronectin, while elongated 
morphology is more common for collagens. Furthermore, a significant decrease in both 
F-actin and vinculin area occurs only for cells on fibronectin matrix. These studies 
demonstrated that ECM regulates the assembly and organization of cytoskeleton in 
VSMCs.   
 
1.3.4  Substrate Stiffness 
In a large number of cardiovascular diseases involving VSMCs, such as 
hypertension, hypertrophy, and atherosclerosis, the stiffness of the diseased blood vessels 
is dramatically altered [100]. Changes in substrate stiffness in two- and three-dimensional 
culture systems lead to VSMC cytoskeletal remodeling. Peyton and colleagues have 
shown that human VSMCs cultured on two-dimensional polyacrylamide gels with a 21 
 
range of stiffness from 1.0 to 308 kPa display more visible F-actin bundles and punctate 
focal adhesion sites on a rigid substrate compared to cells cultured on soft substrates 
[101]. In the same study, they also demonstrated that an intermediate stiffness produces 
an intermediate amount of fibers and focal adhesions. Extending those findings using a 
poly(ethylene glycol)-conjugated fibrinogen based three-dimensional culture system with 
compressive modulus between 448 and 5804 Pa, the group observed a higher level of F-
actin bundling on VSMCs on stiff matrices after 14 days in culture [102]. These results 
suggest that VSMCs actively adapt to stiffness in the microenvironment by remodeling 
stress fiber and focal adhesion organization.  
 
1.3.5  Topography 
A wide range of cell types respond to topographical cues such as grooves, ridge, 
stops, pores, wells, and nodes in micro- and nano-scale [103-107]. VSMCs in their native 
environment also interact with micro- and nano-scaled features such as pores, fibers, and 
ridges on the basement membrane [108]. Studies that mimick these micro- and nano-
scale topographies in vitro have reported active remodeling of cellular cytoskeleton. 
VSMCs seeded on nanopatterned gratings of poly(methyl methacrylate) (PMMA) and 
poly(dimethylsiloxane) (PDMS) assume elongated cell and nuclei shapes [109]. VSMCs 
cultured in micro-channels with channel widths of 20, 30, 40, 50, and 60 µm display 
highly aligned actin filaments and elongated nuclei on narrower micro-channels [110]. 
More recently, Taneja and colleagues evaluated the effect of 13 µm 316L stainless steel 
micro-grooved surface on VSMC phenotypic changes to understand how topography of 
endovascular stent contributes to restenosis [111]. They found that micro-grooved 22 
 
surfaces induce significant cell elongation in addition to significantly higher levels of α-
actin expression [111]. These studies suggest that micro- and nano-scaled topographical 
features can significantly alter the shape of both cell and nucleus and lead to cytoskeletal 
remodeling.  
Altogether, these studies reveal that mechanical properties of the cellular 
microenvironment can be used as design tools to build VSM with engineered cytoskeletal 
architecture in vitro. The cytoskeleton interacts with multiple signaling pathways by 
regulating the activation/deactivation state of associated protein complexes [112]. As a 
consequence of the tight structure-function coupling in VSMC, we would expect that the 
engineered architecture would influence the VSM functional outcome; thus, there exists a 
need for a performance metric that will allow researchers to systematically evaluate and 
optimize the functions of the fabricated VSM tissue.   
 
1.4  Functional Evaluation of Engineered Vascular Smooth Muscle 
Although our ability to control the mechanical properties of the cellular 
microenvironment has become increasingly precise and refined, the ultimate goal for 
tissue engineers is to harness these mechanical cues to build a functional VSM in vitro. 
This aim will require systematic evaluation and optimization of the VSM tissue design 
with a standardized performance benchmark or functional metrics. Conventional standard 
practice evaluates engineered VSM using proteomic assays and cellular morphology; in 
contrast, we will use evidence from in vitro studies to show in the following sections that 
VSM functions, including proliferation, migration, contraction, and gene expression, are 23 
 
influenced by cellular architecture and therefore should be included as part of functional 
evaluation for assessing engineered VSM tissue.  
 
1.4.1  Proliferation 
A growing number of studies demonstrate that the proliferation of engineered 
VSMCs can be influenced by the cytoskeletal architecture in vitro. With micropatterned 
collagen strips of 20, 30, and 50 µm width as well as 30 µm wide micro-grooves on poly-
(D,L-lactide-co-glycolide) (PLGA), Thakar and colleagues showed that significantly 
elongated cell shape and reduced formation of actin stress fiber and α-actin are displayed 
by VSMCs cultured on 20 and 30 µm-wide collagen strips and micro-grooved PLGA 
surfaces [92]. Quantification of proliferation with 5-bromo-2’-deoxyuridine (BrdU) 
showed that these elongated VSMCs have a significantly reduced growth rate. In addition, 
a study of engineered isolated human VSMCs cultured with micropatterned matrix 
islands revealed that cells with elongated shape and nuclei have a lower proliferation rate 
[93]. Aligned and elongated bovine VSMCs engineered on PMMA and PDMS 
nanopatterned gratings have a reduced proliferation rate [109]. Even in the absence of 
direct cellular shape manipulation by ECM pattern or topography, isolated porcine 
VSMCs with a spindle shape also have a significantly lower proliferation rate than 
rhomboid-shaped cells [113]. These studies provide mounting evidence that cytoskeletal 
architecture can regulate VSMC proliferation.  
Since cells can actively respond to extracellular boundary conditions by 
remodeling their cytoskeletal organization [85, 114], changes in cell shape could lead to 
spatially different placement and distribution of mechanosensitive protein complexes, 24 
 
eventually producing changes in signaling pathway and functions. For example, focal 
adhesions tend to localize toward the corners of cells [89, 115]. These intramembrane 
protein complexes transmit mechanical tension from outside of the cell to the 
cytoskeleton inside the cell [116] and modify activation states of associated signaling 
proteins [117]. F-actin stress fibers also anchor on the focal adhesions and nuclear lamina, 
providing a direct physical link for tension to be transmitted to the nucleus [118, 119]. 
These mechanical connections to the nucleus stabilize intranuclear DNA [73], and cell 
shape-induced nuclear deformation can lead to chromatin remodeling and DNS synthesis 
[120]. Collectively, these studies indicate that VSMC proliferation depends on cellular 
shape and cytoskeletal architecture.  
 
1.4.2  Migration 
VSMCs migrate toward the site of vessel injury in response to growth factor 
gradients. Understanding and regulating VSMC migration has been a focus in treating 
vascular diseases for preventing post-surgical complications such as thrombogenesis and 
restenosis. Several studies have demonstrated that VSMC migration depends on VSMC 
shape and cytoskeletal organization. In one study, maximum migration speed was 
observed for isolated human VSMCs with the highest ARs [121]. However, a later report 
showed that cloned human VSMCs under serum-withdrawn conditions and with 
elongated morphology have a significantly lower migration speed [122]. These 
contradictory findings may be attributable to differences in cell types, serum conditions, 
and ECM proteins. A novel isolation method used by Hao et al. to obtain porcine VSMCs 
with distinct spindle and rhomboid morphologies showed that rhomboid-shaped VSMCs 25 
 
migrate significantly faster than spindle-shaped cells [113]. When cytoskeleton 
reorganization is inhibited by cytochalasin D, interlukin-6-induced migration of VSMCs 
is inhibited [123], suggesting that VSMC migration can be regulated by cytoskeleton 
architecture. More recently, Jiang and colleagues showed that phosphomimetic 
caldesmon mutant-transfected rat VSMCs with the most robust expression of actin 
cytoskeleton structure have a significantly lower migration activity compared to VSMCs 
with normal expression of actin cytoskeleton [124]. Taken together, these studies suggest 
VSMC migration may be influenced by cellular architecture.  
 
1.4.3  Contraction 
The main function of quiescent, fully differentiated VSMCs is to contract or 
relax the vessel wall in response to pressure and flow changes. In addition to regulating 
proliferation and migration, which are associated with the synthetic phenotypes of 
VSMCs, cell shape and cytoskeletal architecture mediate the contractile strength of 
VSMCs. In desmin-deficient mice, VSMCs isolated from microarteries exhibit lower 
active and passive tension [125], while isolated VSMCs have higher active force and 
increased passive compliance [126], indicating the contribution of intermediate filament 
on VSMC contractility may be cell type-dependent. Pharmacological studies inhibiting 
actin polymerization with cytochalasin D [43, 45], cytochalasin B [44], and latrunculin B 
[127] found a complete inhibition of contraction in VSMCs. On the other hand, 
enhancing actin polymerization with an actin stabilizer, jasplakinolide, increases 
myogenic tone in rat cerebral VSMCs under intraluminal pressure [47], suggesting that 
actin organization plays a critical role in VSMC contraction generation. More recently, 26 
 
Koltsova and colleagues reported that elevation in F- to G-actin ratios in rat VSMCs with 
hyperosmotic shrinkage and hyposmotic swelling also causes increased contraction [95], 
suggesting that a contractile response is mediated by actin polymerization. In addition to 
actin stress fibers, Min and colleagues found regulation of focal adhesion by Src 
modulates differentiated VSMC contractility [29]. By forcing VSMCs into elongated 
shapes on micropatterned strips of fibronectin and laminin, our group showed an increase 
in VSMC nuclear eccentricity and a higher degree of cell contraction [90], suggesting 
that cell shape may modulate VSMC contractility. Taken together, these studies suggest 
that VSMC contractility is a function of cellular cytoskeletal architecture and cell shape.  
 
1.4.4  Gene Expression 
The expression of genes and proteins has been used traditionally to assess the 
phenotypic state of VSMCs. The activation and deactivation of specific pathways that 
controls the expression of genes can be mediated by cytoskeletal architecture. For 
example, rabbit VSMCs in contractile and synthetic states with different organizations of 
vimentin, actin, and focal adhesion have significantly different expression and 
distribution of smooth muscle-specific proteins [128]. Inhibiting or enhancing actin 
polymerization pharmacologically significantly decreases or increases SMC-specific 
promoter activities, respectively, in rat VSMCs [129], suggesting that actin 
polymerization regulates SMC-specific gene expression. When a single stretch is applied 
to rat VSMCs, significant upregulation of smooth muscle-specific contractile proteins is 
accompanied by an increase in F- to G-actin ratio [81]. However, when the stress fiber 
network is disrupted pharmacologically, stretch-dependent activation of rat VSMC 
differentiation markers is abolished [130], indicating that an intact cytoskeleton is 27 
 
required for activation of SMC-specific genes. In addition, Cattaruzza and colleagues 
reported that zyxin can translocate and accumulate in the nucleus and modulate VSMC-
specific gene expression [10], suggesting that cytoskeletal proteins could be directly 
involved in modulating gene expression. Since the cytoskeleton is mechanosensitive, 
differences in cytoskeletal architecture can lead to differential activation of genes and 
proteins, which ultimately provide VSMCs with functional adaptability.   
 
1.5  Conclusions 
Vascular smooth muscle functions are highly dependent on the structural 
organization in multiple spatial scales as a result of the cellular mechanotransduction 
processes. An engineering algorithm for building functional vascular smooth muscles in 
vitro based on recapitulating the mechanotransduction processes allows us to control for 
both cellular architecture and function. Importantly, cytoskeleton proteins such as 
integrin, cadherin, actin, intermediate filaments, and microtubules embedded in the 
extracellular, intracellular, and intercellular domains are mechanotransductive 
components that contribute to VSMC form and function. By harnessing the mechanical 
cues in the cellular microenvironment, such as cyclic tensile stress, cellular shape 
deformation, ECM interactions, and substrate stiffness and topography, we can build 
functional VSMCs with engineered cytoskeletal architecture. The performance of these 
engineered VSMCs should then be evaluated and optimized with functional metrics 
including proliferation, migration, contraction, and gene expression because of their 
dependency on cytoskeletal architecture. The development of functional VSM in vitro 
models is particularly relevant for engineering small-diameter vascular grafts, where 
functional VSM tissue may improve graft patency and long term survival, and replacing 28 
 
expensive animal models in traditional drug discovery research with a cheaper, functional 
in vitro alternative.  
With this dissertation, we applied this strategy in the design and assembly of 
engineered vascular tissues. In chapter 2, we investigated the effect of engineered VSMC 
shape on its cytoskeletal architecture and contractile strength. In chapter 3, we developed 
a novel three-dimensional tissue patterning strategy based on folding polymer thin sheet 
and tested this strategy for building vascularized networks.    29 
 
2  The Contractile Strength of Vascular Smooth Muscle 
Myocytes is Shape Dependent 
Adapted from Ref. 91 with permission from The Royal Society of Chemistry.  
Vascular smooth muscle cells in muscular arteries are more elongated than those 
in elastic arteries. Previously, we reported changes in the contractility of engineered 
vascular smooth muscle tissue that appeared to be correlated with the shape of the 
constituent cells, supporting the commonly held belief that elongated muscle geometry 
may allow for the better contractile tone modulation required in response to changes in 
blood flow and pressure. To test this hypothesis more rigorously, we developed an in 
vitro by engineering human vascular smooth muscle cells to take on the same shapes as 
those seen in elastic and muscular arteries and measured their contraction during 
stimulation with endothelin-1. We found that in the engineered cells, actin alignment and 
nuclear eccentricity increased as the shape of the cell elongated. Smooth muscle cells 
with elongated shapes exhibited lower contractile strength but greater percentage increase 
in contraction after endothelin-1 stimulation. We analysed the relationship between 
smooth muscle contractility and subcellular architecture and found that changes in 
contractility were correlated with actin alignment and nuclear shape. These results 
suggest that elongated smooth muscle cells facilitate muscular artery tone modulation by 
increasing its dynamic contractile range. 
 
2.1  Introduction 
The contractile function and structure of vascular smooth muscle cells (VSMCs) 
vary as a function of location in the cardiovascular system [131]. In large diameter elastic 30 
 
arteries, such as the aorta, VSMCs contract to maintain vessel pressure during cardiac 
cycle [132]. This is in contrast to mid-sized muscular arteries, such as the external carotid 
artery of the neck and femoral artery of the thighs, where VSM contracts concentrically 
to constrict or relax the arterial wall in a process called vascular tone modulation [133]. 
These functional differences are reflected structurally, where VSMCs exhibit markedly 
different geometries in these arteries. Although differentiated VSMCs in elastic and 
muscular arteries have a characteristically spindle shape, the elongated shape of VSMCs 
in muscular arteries with nearly 15:1 in cell AR, is more pronounced than those found in 
elastic arteries, which have cell AR about 9:1 [131]. It has been speculated that the 
VSMC shape may facilitate vascular tone modulation in muscular arteries by providing 
better dynamic response to blood flow [134, 135] and pressure changes [136]. However, 
definitive evidence to support this relationship between VSMC shape and contractile 
function has been limited. 
VSMCs undergo significant changes in geometry in physiological and 
pathological developments. Domenga and colleagues demonstrated rapid VSMC 
structural changes in postnatal wild-type mice, where VSMCs developed more elongated 
shape, increased thickness and become circumferentially oriented around the lumen by 
day 28 compared to immature VSMCs at birth [137]. Genetic deletion of Notch3, which 
is uniquely expressed in arteries but not of veins, led to thin, irregular, rounded shape 
VSMCs that are poorly orientated around the lumen [137]. In human, Notch3 mutation 
leads to a hereditary vascular dementia called cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopahy (CADASIL), characterized by a 
cerebral non-atherosclerotic, non-amyloid angiopathy that mainly affects the small 31 
 
arteries penetrating the white matter. Patients diagnosed with this disease were usually 
found with more rounded and irregular VSMC shape in small- and middle-sized arteries 
[138]. During normal vascular repair following injury, VSMCs switch their contractile 
phenotype to synthetic phenotype and in the process, changing their shape from the 
elongated spindle morphology to an epithelioid or rhomboid morphology [139]. The 
epithelioid shaped VSMCs proliferate and produce extracellular matrix to help with the 
wound healing process [139]. However, the deregulation of this phenotype switching 
process underlies a number of vascular disorders such as hypertension [140], restenosis 
[141], and vasospasm [14]. This is supported by pathological studies that observed 
morphologically distinct VSMC populations between spindle and epithelioid shapes at 
the site of atherosclerotic intima in the aorta [142-144], carotid artery [145] and coronary 
artery [146]. Understanding the role of VSMC shape change may elucidate mechanistic 
insight in the context of cellular physiology and vascular pathology. 
In addition to VSMCs, shape change also plays an important role in regulating 
the physiological and pathological development of other smooth muscle cells and 
cardiomyocytes. In an early ultrastructural study focusing on the prenatal development of 
smooth muscle in the human fetal uteri between 12-40 weeks of gestation, Konishi et al. 
showed immature uterine SMCs changed from a round morphology at week 12-16 to an 
elongated shape with identifiable dense bodies at week 18 [147]. A clinical and 
pathological analysis of 26 cases of atypical smooth muscle tumours of the uterus 
demonstrated that SMC in leiomyoma changed from the typical elongated shape to a 
rounded, polygonal shape [148]. In cardiac development, cardiac looping is one of the 
first steps of forming a four chambered-heart that requires bending and twisting of heart 32 
 
tube asymmetrically. It was found that myocardium on the concave side of the heart tube 
myocardium remains thick and columnar while the convex side flattened and increased in 
surface area, effectively reducing the AR of the myocardium epithelial tissue [149] and 
resulting in different contractility on the concave and convex surfaces [150]. In mature 
adult heart under pathological chronic pressure overload, the heart undergoes concentric 
hypertrophy, resulting myocytes increase cell width without significant changes in cell 
length. This, in turn, decreases the normal AR from 7:1 [151-153], as seen for normal 
ventricular myocytes, to 5:1 [154, 155]. As heart continues to fail, eccentric hypertrophy 
develops in response to volume overload, which adds sarcomere in series without 
changing myocytes, cross-section area. This eventually increased the myocytes aspect 
ratio to 11:1 [152, 153]. Investigating the shape and contractility relationship in myocytes, 
our group recently reported that myocytes contractility is optimized at AR observed in 
normal hearts and decreased in cardiomyocytes that resemble AR of failing hearts [88]. 
In addition, we observed that boundary condition encoded in the extracellular space can 
regulate myocyte tissue cytoskeletal alignment and function [85, 156, 157]. These studies 
clearly demonstrated that shape adaptations in smooth and striated muscles can 
profoundly influence the cellular function.  
Recent advances in technologies designed to engineer and probe cell geometries 
and mechanics has enabled studies demonstrating the relationships between cell shape 
and architecture and cellular functions such as apoptosis [158], proliferation [120], 
cytoskeletal and focal adhesion organization [85, 159, 160], and contraction [88, 89, 157]. 
Utilizing micro-fabrication techniques, our group as well as others have demonstrated at 
a tissue level that VSM seeded in microgrooves and micropatterned fibronectin (FN) 33 
 
assumed an elongated morphology [87] as well as oriented remodelling of the underlying 
matrix [161] and significantly lower cell proliferation rate [93]. Recently, focusing on 
VSM tissue structure and contractility, we showed that contractile stress of VSMC tissue 
increased as cell shape elongated within the tissue [90], suggesting that VSM contractility 
is potentially cell shape dependent. Elsewhere, Wang and colleagues sparsely seeded 
VSMCs on polyacrylamide (PAA) gel with an isotropic type-I collagen coating and 
measured an increase in contractile force as cell spreading increased [162]. In another 
study where VSMC spreading was controlled [93], elongated VSMCs showed reduced 
proliferation, a cell function commonly associated with cell shape and cytoskeletal 
tension. While these reports suggest that VSM tissue and cellular structure could 
influence its function, the role of cell shape in vasomotor tone and contractility was not 
elucidated. This is important, because controlling cell shape in tissue engineered vascular 
grafts may be an important strategy for endowing the tissue with a specific drug 
sensitivity and high fidelity control of the lumen diameter. 
We hypothesized that forcing VSMCs to assume increasingly elongated shapes 
would mimic the VSMC morphology in muscular arteries in vivo and induce changes in 
the intracellular architecture that consequently increase the dynamic contractile range of 
VSMC in response to contractile stimuli. To test this hypothesis, we engineered VSMCs 
on micropatterned islands of fibronectin (FN) with ARs of  5:1, 10:1 or 20:1 to mimic 
VSMC shapes found in elastic and muscular arteries in vivo, quantified cytoskeletal and 
nuclear organization, and directly measured contraction via traction force microscopy 
(TFM) upon stimulation with a vasoconstrictor endothelin-1 (ET-1). We found cell shape 
significantly influenced cytoskeletal and nuclear organization and isolated VSMCs of AR 34 
 
near 20:1 achieved lower basal and stimulated contractile forces but greater percent 
change in contractile force after stimulation. These results suggest that the elongated 
shape equips VSMC with a greater dynamic contractile range, facilitating modulation of 
vascular tone over a broad range by muscular arteries in vivo. 
 
2.2  Results 
2.2.1  Design of Vascular Smooth Muscle Cell Shape 
We engineered the isolated VSMCs by designing three cellular structure 
parameters: geometry, size and AR. The geometry refers to the number of vertex that the 
isolated VSMC has. For example, circular or ellipsoidal shaped VSMCs have zero 
vertices and they belong to the same geometry class. Extending this concept, a spindle-, 
triangular- and rectangular-shaped VSMC has two, three and four vertices respectively, 
and they represent three different geometrical classes.  
Although healthy, fully differentiated VSMCs usually assume a spindle-like 
shape in vivo, we designed our isolated VSMCs with a rectangular geometry for two 
reasons. First, isolated VSMC with tapered, spindle-like geometry may be a poor in vitro 
model. Kuo and colleagues demonstrated that airway smooth muscle cells work as a 
mechanical syncytium by transmitting intercellular force along the principle axis of the 
cells through mechanically coupled nucleus and aligned F-actin filaments, despite the 
individual spindle cell shape [72]. They argued when mechanical coupling between 
neighboring cells are absent, force generation in cells may be distorted, unless the 
isolated smooth muscle cells are long and the tapered ends are not included in the 
mechanical measurements. Therefore, by designing our isolated VSMCs in rectangular 35 
 
geometry, we ascertain the isolated VSMCs are long and without the tapered ends and 
this allowed us to measure the mechanical output of the entire cell body. The second 
reason for using a rectangular geometry is a technical one: the longitudinal end-to-end 
distance is shorter for rectangular geometry than for spindle geometry of the same surface 
area. This allows us to fit the entire isolated VSMC in one field of view on our 
microscope when using the 40× objective with a 0.5× optical zoom, up to 20:1 length to 
width AR. Although grid imaging software can address this issue, it is not preferred in 
this experimental setup as grid imaging and stitching can introduce error in fluorescent 
bead location for traction force microscopy and require additional laser exposure cycles, 
which can be phototoxic to cells for extended live cell imaging. Based on the above two 
reasons, we designed and engineered our isolated VSMCs to be rectangular in geometry 
for all studies. 
We asked what projected surface area we should use for designing our isolated 
VSMCs. It is important to have a constant projected surface area for all ARs as smooth 
muscle cell spreading has been shown to influence cellular function [92]. Since substrate 
stiffness can lead to changes in cell spreading area [101, 163, 164], we investigated the 
spreading behavior of VSMCs on both soft (13 kPa) polyacrylamide (PAA) gel [165] and 
much stiffer glass (73 GPa) substrates. To present identical extracellular matrix (ECM) to 
the cells, we patterned both substrates with biotinylated-fibronectin isotropically. We 
induced the contractile phenotype and inhibited cell division by serum starving the 
VSMCs for 48 hours following an initial 24 hour seeding period with media containing 
10% fetal bovine serum (See Materials and Methods). We stained the cell membrane with 
DiO and the nucleus with DAPI in order to measure the spreading area of single VSMCs.  36 
 
We observed a spectrum of morphology in isolated VSMCs on both PAA gel 
(Figure 2-1 A-C) and glass (Figure 2-1 D-F) substrates. We categorized the morphology 
into rhomboid (Figure 2-1 A, D), elongated (Figure 2-1 B, E) and spindle (Figure 2-1 C, 
F). For some of the spindle-shaped isolated VSMCs, cell length can extend over 300 µm 
(Figure 2-1 C). 
 
Figure 2-1: Morphology of immunostained isolated vascular smooth muscle cells on 
soft (13 kPa) polyacrylamide (PAA) gel (A-C) and stiffer (73 GPa) glass (D-F) substrates 
isotropically patterned with biotinylated-fibronectin. (White: DiO, blue: DAPI). On both 
substrates, a diverse morphology including rhomboid (A, D), elongated (B, E) and 
spindle (C, F) were observed. Scale bars = 50 µm. 
We measured the projected surface area of single VSMCs by manually tracing 
the cell borders in ImageJ. We found the projected surface area of single VSMCs on PAA 37 
 
gel (Figure 2-2 A) and glass (Figure 2-2 B) to be normally distributed with a mean at 
4000 µm2 and 3500 µm2 respectively. This is consistent with a previous study that found 
the spreading area of human aortic SMCs was normally distributed [166].  To provide a 
physiologically relevant substrate stiffness, we microfabricated all isolated VSMCs in 
subsequent studies with a projected surface area of 4000 µm2 on PAA gel to minimize the 
effect of cell spreading area on cellular function. 
 
Figure 2-2: Projected surface area of isolated vascular smooth muscle cells is 
normally distributed on PAA gel (A) and glass (B) substrate. The mean projected surface 
area of VSMCs on PAA gel is higher than those on glass. (Solid line: normal distribution, 
red dotted line: mean). 
Finally, in order to determine physiologically relevant ARs for designing our 
experiment, we surveyed the literature for measurement of AR observed in previous in 
vivo [131] and in vitro [90, 92, 93, 161, 167, 168] studies. A wide spectrum of ARs for 
VSMCs was observed ranging from 2 to 50 in studies in the past 3 decades (Figure 2-3). 
We selected the 20:1 AR as the upper limit for our study as (1) all studies except one 38 
 
showed that VSMC ARs did not exceed 20:1 in Figure 2-3 and (2) 20:1 is the upper limit 
for a single field of view of the entire cellular body, which reduced cellular phototoxicity 
and improved signal to noise ratios during traction force microscopy. We selected 5:1 AR 
as the lower limit for our study as (1) it is just below the 8:1 AR observed in vivo (Figure 
2-3, pink bar) and (2) it permits sufficient cell shape polarization to remain rectangular. 
We also selected one intermediate AR of 10:1 to study the transition between the upper 
and lower bounds. Taken together, from the selected geometry, size and ARs above, our 
finalized design for microfabricated isolated VSMCs were rectangular islands with a 
fixed projected surface area of 4000 µm2 and ARs of 5:1 (141 × 28 µm), 10:1 (200 × 20 
µm) and 20:1 (282 × 14 µm). 
 
Figure 2-3: Observed aspect ratios of vascular smooth muscle cell from literature.  
In vitro (pink) VSMC ARs range between from 10:1 to 15:1 while in vitro (blue) VSMC 
ARs range between from 2:1 to 50:1.   
 
2.2.2  Microfabricated Isolated Vascular Smooth Muscle Cells 
To fabricate isolated VSMCs according to our design parameters, we adopted 
methods previously established in our group [88, 89] by culturing VSMCs in defined 39 
 
media on elastic, 13 kPa PAA gels whose surfaces had been micropatterned with 
rectangular FN islands (Figure 2-4). For details, please see Methods and Materials section.  
 
Figure 2-4: Schematic representation of µCP method on polyacrylamide gel to 
construct isolated vascular smooth muscle cells with different aspect ratios. For 
details, please see Method and Materials section.   
To examine the quality of the micropatterned FN islands, we immunostained the 
islands with anti-human FN and found them to be uniform and consistent with high 
fidelity (Figure 2-5 A). After 1 day of culture in 10% FBS serum followed by 2 days of 
culture in serum-free media on PAA gel with FN islands, seeded VSMCs assumed the 
rectangular shape of the patterned FN islands with aspect ratio of 5:1, 10:1 and 20:1 
(Figure 2-5 B). By optimizing the initial seeding density, we were able to obtain mostly 
island with a single cell present. However, islands occupied with more than one cell were 
also occasionally observed (Figure 2-5 B, arrowhead). 
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Figure 2-5: Immunostained micropatterned FN islands and microfabricated isolated 
vascular smooth muscle cells. (A) Anti-human FN staining of patterned biotin-FN on 
PAA gel. (B) Phase contract images of micropatterned isolated VSMCs with aspect ratio 
of 5:1, 10:1 and 20:1 and surface area of 4,000 µm2. Islands occupied by more than one 
cell had a sinusoidal cell-cell junction (arrow head). (A-B) Scale bars = 100 µm. 
We measured the projected surface area, AR and thickness of isolated VSMCs 
to ascertain the quality and fidelity of the microfabrication process. We immunostained 
isolated VSMCs of AR 5:1 (Figure 2-6 A), 10:1 (Figure 2-6 B) and 20:1 (Figure 2-6 C) 
with phalloidin to visualize the cell shape and DAPI to ensure that only single cells were 
measured. We found that the projected surface areas were similar for all three ARs with 
mean at 2225 ± 48 µm2 (Figure 2-6 D). Since VSMCs exert a basal tone at normal resting 
condition, the reduction in projected surface area is expected as a result of elastic 
deformation of the soft PAA substrate under cell generated force. The contraction of 
isolated VSMCs also lead to shape deformation as we found that mean and SEM of ARs 
of 5:1, 10:1 and 20:1 were 6.8 ± 0.1, 15.3 ± 0.5, 31.3 ± 1.4 respectively. The findings that 
all three cellular ARs were more elongated than the original design may suggest that 41 
 
contraction in cell’s short axis changed by a greater proportion than the contraction in the 
long axis. 
 
 
Figure 2-6: Characterization of microfabricated immunostained isolated vascular 
smooth muscle cells. (A-C) Phalloidin and DAPI stained patterned isolated VSMCs with 
AR of 5:1 (A), 10:1 (B) and 20:1 (C). (White: F-actin, blue: nuclei). Scale bar = 50 µm. 
(D) Measured projected surface area and AR of isolated VSMCs. Mean ± SEM. n = 17-
26 cells from 2-3 coverslips per condition. 
To get a sense quantitatively in terms of the magnitude of the contractions in 
cell’s short and long axes, we calculated the shortenings in both directions by assuming 
the rectangular isolated VSMCs contracted concentrically (Figure 2-7 A). This 
assumption is based on the observed rectangular shape of contracted isolated VSMCs in 
Figure 2-5. Since we know the original length (L) and width (W) of the micropatterned 
FN islands, we can use the following two equations based on the measured projected 
surface area and cell AR (Fig. 6D) to solve for shortenings in the cell’s long (2a) and 
short axes (2b): 
𝑃𝑟𝑜𝑗????? ?𝐴 = (𝐿 − 2?) × (? − 2?)                             (1) 42 
 
𝐶?𝑙𝑙 𝐴? = (𝐿 − 2?) (? − 2?) ⁄                                           (2) 
The magnitude (Figure 2-7 B) of shortenings calculated using this simplistic 
model showed that cell elongation leads to statistically greater shortening in cell’s long 
axis at 20:1 ARs but significantly less shortening in cell’s short axis at 10:1 and 20:1 ARs, 
suggesting that  cell shape can influence the magnitude and distribution of contraction. 
Normalizing the magnitude of shortenings by the original dimensions of the 
micropatterned FN islands, we found that a significantly lower relative shortening in 
cell’s long axis was achieved by isolated VSMCs with 20:1 ARs while similar relative 
shortenings in cell’s short axis were achieved by all three ARs (Figure 2-7 C). This result 
suggests that as VSMC becomes elongated, contraction in the cell’s long axis becomes 
weaker. In addition, the relative shortening in the short axis is much higher than the 
shortening in the long axis, which supports our earlier suggestion that a greater 
proportion of contraction is achieved in the cell’s short axis than the long axis. 43 
 
 
Figure 2-7: Shortening of rectangular isolated vascular smooth muscle cells. (A) 
Schematic illustration of concentric shortenings in cell’s long (2a) and short (2b) axis. L 
and W are the length and width of the micropatterned FN island respectively. (B) 
Magnitude of shortening in cell’s long (black) and short (red) axes. (C) Percent 
shortening compared to original micropatterned FN island dimensions in cell’s long 
(black) and short (red) axes. (B-C) * = statistically different from 5:1 AR, † = statically 
different from 10:1 AR, ‡ = statistically different from 20:1 AR. p < 0.05. Mean ± SEM. 
n = 17-26 cells from 2-3 coverslips per condition. 44 
 
We measured cell thickness using deconvolved three-dimensional confocal 
image stack of phalloidin labeled F-actin fibers of isolated VSMCs (Figure 2-8 A).  No 
statistically significant difference in cell thickness was observed between the three ARs 
(Figure 2-8 B). Since the measured projected surface areas were similar (Figure 2-6), this 
result suggested the cell volume was conserved for all three ARs. Taken together this 
approach enabled us to control the shape of isolated VSMCs with high precision while 
maintaining cell spreading area, substrate stiffness, growth factor and ECM composition. 45 
 
 
Figure 2-8: Vascular smooth muscle cell thickness and volume are similar for all 
aspect ratios. (A) Three dimensional rendering of a 5:1 AR VSMC patterned on PAA 
gel. (Red: F-actin, blue: nucleus). Scale bar = 20 µm. Isolated VSMC thickness (B) and 
volume (C) as a function of VSMC AR. (B-C) mean ± SEM. n = 7-12 cells per AR.  
 
2.2.3  F-actin Alignment and Organization as a Function of Cell Shape 
Previously, we reported variations in cell shape, cytoskeletal alignment, and 
nuclear shape in engineered vascular tissues assembled on matrix templates with varying 
geometries [90]. We endeavored to study this cellular remodeling under more controlled 
conditions. In our engineered cells, we measured the alignment of F-actin (Figure 2-6 A-46 
 
C, 5:1, 10:1 and 20:1 respectively) using immunohistochemical staining. The orientation 
of the F-actin fibers was calculated using a method based on structure tensor method [169] 
and quantified by calculating the orientational order parameter (OOP), a method 
borrowed from crystallography and previously reported by our group [170]. We found 
that F-actin OOP increased significantly as cell AR increased (Figure 2-9), suggesting 
that as the cell’s long axis was extended, the transverse boundary conditions on the cell 
potentiated the alignment of polymerizing actin with the cell’s long axis. 
 
 
Figure 2-9: Orientational order parameter (OOP) of F-actin fibers of isolated 
vascular smooth muscle cells. VSMCs with higher ARs had a greater F-actin OOP value, 
suggesting more aligned F-actin fibers. * = statistically different from 5:1 AR, † = 
statically different from 10:1 AR, ‡ = statistically different from 20:1 AR. p < 0.05. All 
bars: mean ± SEM. n = 7-12 cells per AR. 
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2.2.4  Nuclear Deformation as a Function of Cell Shape 
The cell nucleus interacts with cytoskeleton [118] and deforms when 
extracellular stresses were applied [171]. Changes in nuclear shape have been proposed 
to cause conformational changes in chromatin structure and subsequently influence 
transcriptional level and cell function [172]. We characterized nuclear shape changes by 
measuring the changes in nuclear angle offset, projected area and eccentricity (Figure 2-
10 A-C, 5:1, 10:1, and 20:1, respectively) by manually outlining the stained nuclei in the 
plane of the culture surface (Figure 2-10 D). Nuclear angle offset, which measures the 
difference in orientation between the major axes of the ellipse that best fits the cell body 
and nucleus (Figure 2-10 A), was significantly lower for cells with 20:1 ARs (Figure 2-
10 E). The projected area of the nucleus in these cells was found to decrease significantly 
for cells with 10:1 and 20:1 ARs (Figure 2-10 F). Consistent with previous findings [90], 
nuclear eccentricity significantly increased as cell AR increased (Figure 2-10 G). 
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Figure 2-10: Morphological changes in nuclear shape as isolated vascular smooth 
muscle cell elongates. (A-C) Manual traces of cell border with nuclei of isolated VSMCs. 
(Magenta: cell border, blue: nuclei). Nuclear orientation offset, θ, is shown between the 
two dotted white lines in (A), representing the major axes of the ellipses that best fit the 
cell body and nucleus respectively. Scale bar = 50 µm. (D) Superimposed nuclear 
outlines from cells in A-C show clearly the difference in nuclear eccentricity, orientation 
offset and projected area as cell AR increases. (H) F-actin orientational order parameter 
(black) and nuclear orientation offset (red) as a function of VSMC ARs. (I) Nuclear 
eccentricity (black) and projected area (red) as a function of VSMC ARs. * = statistically 49 
 
Figure 2-10 (Continued) different from 5:1 AR, † = statically different from 10:1 AR, ‡ = 
statistically different from 20:1 AR. p < 0.05. (E-G) mean ± SEM. n = 7-12 cells per AR. 
 
We wanted to test whether changes in nuclear morphology could be explained 
by a decrease in nuclear volume resulting from cell lengthening [120]. Based on three-
dimensional rendering of nucleus (Figure 2-11 A), we assumed an ellipsoid morphology 
for the nucleus (Figure 2-11 B) and quantitatively evaluated the length, width and height 
of the ellipsoid (Figure 2-11 C). However, we found that nuclear volume and nuclear 
surface area were conserved at 475 ± 32 µm3 and 464 ± 21 µm2, respectively, 
independent of alterations in AR (Figure 2-11 D). These data suggested that the elongated 
cell shape leads to higher degree of nuclear deformation, without any change in nuclear 
volume. 
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Figure 2-11: Nuclear volume and surface area of isolated vascular smooth muscle 
cells. (A) A Three-dimensional rendering of 5:1 AR VSMC nucleus. Scale bar = 20 µm. 
(B) Schematic representation shows the half-length (a, red), the half-width (b, blue) and 
half-height (c, black) of a nucleus with assumed ellipsoid shape. (C) Measured nuclear 
dimensions from three-dimensional confocal image stacks as a function of cell AR. * = 
statistically different from 5:1 AR. (D) Nuclear volume and surface area do not differ 
significantly between different cell ARs. (C-D) mean ± SEM. n = 7-12 cells per AR. 
 
2.2.5  Development of Stimulation Protocol for Studying Cell Contraction 
The primary contractile function of elongated VSMCs in muscular arteries is 
local tone modulation in response to systemic and local signals to contract or relax the 51 
 
vessel wall [173]. We hypothesized that in our in vitro system, the elongated VSMC 
shape would improve its dynamic contractile range in response to an external stimulus. 
To test this hypothesis, we used traction force microscopy to measure the force generated 
by cells on the PAA gel substrate when stimulated with a vasoconstrictor, endothelin-1 
(ET-1), to induce cell contraction or rho-associated kinase (ROCK) inhibitor, HA-1077, 
to induce cell relaxation. Since VSMCs respond to stimulations on the order of minutes 
to hours [90], we first assessed the amount of time needed for VSMC traction to 
equilibrate after we dose the drugs. We imaged the cells every 4 minutes and found that 
isolated VSMCs produced a constant traction force prior to ET-1 dosing, which is known 
as basal tone (Figure 2-12). After ET-1 was added, we observed a small but noticeable 
gradual increase in cell traction until it peaked 16 minutes later. In the next 30 minutes, 
the traction gradually decreased until it returned to baseline level. We subsequently dosed 
HA-1077 to the imaging media and noticed an immediate and dramatic decrease in 
traction until 16 minutes later, where it equilibrated near zero. These results suggested 
that isolated VSMCs could equilibrate their traction output within 16 minutes after drug 
dosing. 
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Figure 2-12: A representative traction profile for an isolated vascular smooth 
muscle cell in response to endothelin-1 and HA-1077 treatment. A constant basal tone 
was maintained for the first 24 minutes. After ET-1 at 100 nM was added, traction 
peaked in about 16 minutes but returned gradually to basal level in about 28 minutes. A 
saturating dose of rho-associated kinase (ROCK) inhibitor HA-1077 at 100 µM caused an 
immediate and dramatic decrease in traction and eventually diminished close to 0 after 16 
minutes. 
In order to allow sufficient time for VSMC to equilibrium after drug dosing and 
to minimize the amount of potential phototoxicity caused by excessive laser exposure, we 
developed a TFM protocol to measure contractile strength of isolated VSMC with 
varying ARs exerted on the substrate pre- and post-stimulation with ET-1 (Figure 2-13 
A). Prior to stimulation, we imaged the basal tone of isolated VSMCs. At 8 minutes, we 
stimulated contraction of the isolated VSMCs with a 100 nM dosage of ET-1. At 31 
minutes, we treated cells with a 100 µM dosage of HA-1077, to induce relaxation of the 53 
 
cells. Finally at 60 minutes, we terminated the experiment by trypsinizing the cells from 
the substrate such that there was no traction on the substrate in order to establish a 
reference for calculation of bead displacements. For each condition, three consecutive 
images separated by 4-minute intervals were taken to ensure consistency in VSMC 
contractile output and to minimize potential phototoxic effect of laser imaging. This 
protocol allowed us to assess the contractile strength of isolated VSMCs in response to 
external stimuli while minimizing potential phototoxicity during live imaging. 
 
2.2.6  Quantification of Vascular Smooth Muscle Cell Contractile Strength by 
Traction Force Microscopy 
Prior to stimulation, we ascertained that isolated VSMCs fully occupied the 
rectangular FN islands by differential interference contrast (DIC) imaging. High fidelity 
rectangular isolated VSMCs with AR of 5:1 (Figure 2-13 B), 10:1 (Figure 2-13 C) and 
20:1 (Figure 2-13 D) were selected for TFM experiment. We defined the AR of an 
isolated VSMC at its basal state prior to stimulation as the cellular AR. As a convention, 
we further defined the longitudinal and transverse directions of isolated VSMCs as the x- 
and y- axes, respectively (Figure 2-13 B). Prior to ET-1 stimulation, basal traction 
stresses were observed for isolated VSMCs with AR of 5:1 (Figure 2-13 E), 10:1 (Figure 
2-13 F) and 20:1 (Figure 2-13 G). Following ET-1 stimulation, traction stress intensity 
and area both increased for AR 5:1 (Figure 2-13 H), 10:1 (Figure 2-13 I) and 20:1 (Figure 
2-13 J) isolated VSMCs. After HA-1077 treatment, traction stress was significantly 
reduced for isolated VSMC with AR of 5:1 (Figure 2-13 K) and completely absent for 
AR of 10:1 (Figure 2-13 L) and 20:1 (Figure 2-13 M). After cells were detached by 54 
 
trypsin, traction stress was completely absent for all ARs (Figure 2-13 N-P, respectively). 
For all three ARs, we observed that the basal (Figure 2-13 E-G) and ET-1 stimulated 
(Figure 2-13 H-J) traction stresses were localized at the two ends of the cells and pointed 
towards the geometric centre of the cell where the nucleus is generally located. This 
phenomenon became more pronounced for isolated VSMCs with AR 10:1 (Figure 2-13 F, 
I) and AR 20:1 (Figure 2-13 G and J). This result suggests that focal adhesion complexes 
formed by isolated VSMCs were localized towards the two ends of the cells.  
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We first quantified the contractile strength of isolated VSMCs by computing the 
strain energy (U) [174] from beads displacements at basal, stimulated, and relaxed 
conditions with respect to cell-free reference condition. Strain energy is a scalar 
measurement that integrates tractions exerted in all directions (Figure 2-14 A), which 
enabled us to measure the overall changes in cell contraction. In response to ET-1 
stimulation, the isolated VSMCs further contracted, increasing the measured strain 
energy from the initial basal tone (Ub) to a higher level, here denoted as Uc (Figure 2-14 
B). Both Ub and Uc were relatively constant over the period measured, indicating that 
equilibrium contractions have been reached. To assess the dynamic contractile range of 
isolated VSMCs in response to ET-1, we computed the relative contractile increase in 
strain energy (Ku) by normalizing the increase from basal tone to the ET-1 stimulated 
tone with the basal tone. These measurements allowed us to quantitatively assess both the 
absolute magnitude and relative changes in contractile strength of isolated VSMCs in 
response to external stimuli.  
 
2.2.7  Isolated Vascular Smooth Muscle Cell Contractile Strength Correlated with 
Cellular Aspect Ratio 
To characterize how cell shape affects the contractile strength of isolated 
VSMCs, we plotted the AR of each isolated VSMC against its measured Ub, Uc and KU. 
We found that Ub (Figure 2-14 C) and Uc (Figure 2-14 D) both negatively correlated with 
cell AR. This suggested that the absolute contractile strength of isolated VSMC weakens 
as they elongate. However, relative contractile increase (Figure 2-14 E, KU) significantly 
increased as cell AR increased, which indicates that elongated VSMCs exhibited a 57 
 
greater percent change in contractile strength in relation to its basal tone after stimulation 
with ET-1. Taken together, these results suggest that elongation of the cell AR causes a 
decrease in contractile strength but an increase in overall dynamic contractile range of the 
cell. 
 
Figure 2-14: Vascular smooth muscle cell aspect ratios correlated with strain energy 
output. (A) Schematics illustrating calculations for strain energy from beads 
displacement and traction force of an isolated VSMC at basal (Ub) and after stimulation 
with ET-1 (Uc). (B) Representative temporal strain energy profiles of isolated VSMCs 
with AR 5:1 (lower bound) and 20:1 (upper bound) prior and post stimulation. Relative 58 
 
Figure 2-14 (Continued) contractile increase in strain energy (KU) is defined as the per 
cent change in strain energy from basal to ET-1 stimulated. Ub (C), Uc (D) and KU (E) 
plotted as a function of isolated VSMC ARs. (C-E) The correlation efficient, r, is 
determined by linear regression analysis. Reported p values for Pearson correlations are 
two-tailed, demonstrated that the correlation is significantly different from zero. 
To gain further insight into the component breakdown of the contractile strength, 
we computed the contractile traction force of isolated VSMCs [174] similar to strain 
energy from beads displacement at basal, stimulated and relaxed conditions in reference 
to cell-free condition. Since traction force is a vector measurement, we could probe for 
changes in contractile strength either in the cell’s long axis (longitudinal, Figure 2-15 A) 
or short axis (transverse, Figure 2-16 A). Similar to strain energy, we observed a relative 
constant contraction force in both longitudinal (Tbx, Figure 2-15 B) and transverse (Tby, 
Figure 2-16 B) directions prior to ET-1 stimulation, indicative of the cell basal tone. In 
response to ET-1 stimulation, the isolated VSMCs contracted, increasing the measured 
longitudinal traction force from the initial basal tone (Tbx) to a higher level, here denoted 
as Tcx (Figure 2-15 B). Similar increases were also observed in transverse traction force 
(Tcy, Figure 2-16 B) suggesting isolated VSMC contracts in all directions. We again 
computed the relative contractile increase in the longitudinal (KTx) and transverse (KTy) 
directions by normalizing the increase in traction force with the basal tone force. We 
found in the longitudinal direction that while Tbx and Tcx are negatively correlated with 
the cell ARs (Figure 2-15 C-D), KTx showed a significant positive correlation (Figure 2-
15 E), suggesting that as VSMC elongates, its contractile range increased at the expense 
of lower absolute contractile strength.  59 
 
 
Figure 2-15: Vascular smooth muscle cell aspect ratios correlated with longitudinal 
traction force. (A) Schematics illustrating calculations for longitudinal traction force of 
an isolated VSMC at basal (Tbx) and after stimulation with ET-1 (Tcx). (B) Representative 
temporal longitudinal traction force profiles of isolated VSMCs with AR 5:1 (lower 
bound) and 20:1 (upper bound) prior and post stimulation. Relative contractile increase in 
longitudinal traction force (KTx) is defined as the per cent change in longitudinal traction 
force from basal to ET-1 stimulated. Tbx (C), Tcx (D) and KTx (E) plotted as a function of 
isolated VSMC ARs. (C-E) The correlation efficient, r, is determined by linear regression 60 
 
Figure 2-15 (Continued) analysis. Reported p values for Pearson correlations are two-
tailed, demonstrated that the correlation is significantly different from zero. 
However, in the transverse direction, no correlation was found between cell AR 
and Tby, Tcy and KTy (Figure 2-16 C-E), suggesting that longitudinal contraction is the 
main driving factor for observed difference in contractile output as cell elongates. Taken 
together, our results suggest that cell shape elongation increase the contractile range and 
decrease the contractile magnitude only in the direction of elongation. 
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Figure 2-16: Transverse traction force is similar for all cellular aspect ratios. (A) 
Schematics illustrating calculations for transverse traction force of an isolated VSMC at 
basal (Tby) and after stimulation with ET-1 (Tcy). (B) Representative temporal transverse 
traction force profiles of isolated VSMCs with AR 5:1 (lower bound) and 20:1 (upper 
bound) prior and post stimulation. Relative contractile increase in transverse traction 
force (KTy) is defined as the per cent change in transverse traction force from basal to ET-
1 stimulated. Tby (C), Tcy (D) and KTy (E) plotted as a function of isolated VSMC ARs. 
(C-E) The correlation efficient, r, is determined by linear regression analysis. Reported p 62 
 
Figure 2-16 (Continued) values for Pearson correlations are two-tailed, demonstrated that 
the correlation is significantly different from zero. 
We asked if the increase in relative contractile increase in longitudinal direction 
(KTx) is solely caused by the decrease in basal tone force (Tbx). To address this question, 
we computed the ET-1 stimulated contractile force increase for each individual cell and 
plotted it against its ARs (Figure 2-17). We found that there is a wide distribution in 
traction force increase induced by ET-1 at all ARs and no statistically significant 
correlation was found. This suggests that ET-1 induced the same level of contraction in 
cell’s long axis regardless of the cell AR and the decrease in basal tone force (Tbx) is play 
an important role in the decrease of relative contractile increase (KTx ). 
 
Figure 2-17: Endothelin-1 induced increase in longitudinal traction force is similar 
for all cell aspect ratios. A wide distribution in the absolute increase of longitudinal 
traction force was found for all cellular aspect ratios 
In cellular tensegrity model, tensile stress, known as prestress, bore by the F-
actin filaments are responsible for stabilizing the cytoskeletal network that gives the cell 63 
 
shape [175]. Assuming that the force transmitted along the F-actin fibers are balanced by 
the traction force generated at the cell-substrate interface (Figure 2-18 A), cumulative 
prestress in the F-actin fibers can be obtained by dividing the longitudinal traction force 
(Tx) over the cross-sectional area (A’) of the cell that is perpendicular to the cell’s long 
axis. Since isolated VSMC thickness (Figure 2-8 B) remains constant while cell width 
(Figure 2-7 B) decreased as cell shape elongates, the cross-sectional area (A’), the 
product of cell width and cell thickness, must decrease proportionally as cell width is 
reduced. By dividing the measured longitudinal traction forces Tbx (Figure 2-15 C) and 
Tcx (Figure 2-15 D) by the cross-sectional area, we calculated the cumulative prestress at 
basal state (Pbx) and after ET-1 stimulation (Pcx) (Figure 2-18 B).  We found that Pbx 
(Figure 2-18 C) and Pcx (Figure 2-18 D) increased as cell AR increased respectively, 
suggesting that a higher tensile stress is experienced for F-actin fibers of elongated cells. 
Similar to strain energy and traction forces, we calculated the relative contractile increase 
in cumulative prestress (KPx, Figure 2-18 E) by normalizing the increase in prestress (Pcx 
– Pbx) to basal prestress (Pbx). We found that KPx increased significantly with respect to 
cell AR, suggesting that the changes in actin fiber prestress increased more in cells with 
higher cell ARs than those with shorter ARs.  64 
 
 
Figure 2-18: Vascular smooth muscle cell aspect ratio correlated with longitudinal 
cumulative cellular prestress. (A) Schematics showing a free-body diagram of a section 
of cell. Traction forces at the cell-gel interface (tA’) must be balanced by the internal 
stress in the cell body (PxA”), mainly by the tension bearing actin fibers. In the force 
balance, PxA” = tA’ = Tx, where Px is the cumulative prestress, t is the traction stress, A’ 
is the cell-gel interfacial area, A” is the cross-sectional area of the cell section, and Tx is 
the measured longitudinal traction force. (B) Representative temporal longitudinal 
cumulative prestress profiles of isolated VSMCs with AR 5:1 (lower bound) and 20:1 
(upper bound) prior and post stimulation. Relative contractile increase in longitudinal 
cumulative prestress (KPx) is defined as the per cent change in longitudinal cumulative 
prestress from basal to ET-1 stimulated. Pbx (C), Pcx (D) and KPx (E) plotted as a function 
of isolated VSMC ARs. (C-E) The correlation efficient, r, is determined by linear     65 
 
Figure 2-18 (Continued) regression analysis. Reported p values for Pearson correlations 
are two-tailed, demonstrated that the correlation is significantly different from zero. 
 
2.2.8  Cell Shortening as a Function of Cell Shape 
A previous study demonstrated that more polarized cells have reduced Rho-
dependent actomyosin contractile activity [176]. We asked if the reduction in overall 
force generation is a result of fewer actomyosin cross-bridge cycling activities in VSMCs 
with more aligned F-actin fibres. Since cross-bridge cycling directly leads to cell 
shortening [177], we quantified longitudinal cell shortening (ΔL) from the changes in cell 
length during contraction with respect to basal and relaxed states (Figure 2-19 A). We 
found that ΔL increased for VSMC with higher ARs (Figure 2-19 B) and this increase is 
positively correlated with OOP values (Figure 2-19 C). These results suggested that 
cross-bridge cycling is unlikely to be the cause for the reduction in overall force 
generation.  
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Figure 2-19: Longitudinal cell shortening correlated with cellular aspect ratio and 
orientational order parameter. (A) DIC images showing longitudinal cell shortening 
(ΔL) of a 20:1 AR VSMC calculated from cell length difference on both ends of cell 
body between basal and relaxed conditions. Scale bar = 20 µm. ΔL as a function of cell 
AR (B) and OOP (C). The correlation coefficient, r, is determined by linear regression 
analysis. (B-C) Reported p value is two-tailed, demonstrating that the correlations are not 
significantly different from zero. (B): n = 14-17 cells from 4-6 experiment per AR. (C): n 
= 13-18 cells per condition. All error bars are mean ± SEM. 
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2.2.9  Contractility Correlated with Subcellular Organization 
We asked whether differences observed in F-actin cytoskeletal organization 
would reflect the differences in contractility of the cells. To answer this question, we 
grouped isolated VSMCs into 5:1, 10:1 and 20:1 ARs and compared their actin 
alignments with initial basal tone (Tbx) and relative contractile increase (KTx). We found 
that as OOP increased, Tbx decreased while KTx increased (Figure 2-20 A), suggesting 
that more aligned F-actin fibres enables greater relative increase in force generation along 
the fibre direction at the expense of weakened overall force output.  
Nuclear shape and surface area is influenced by cell morphology [178] and 
subsequently affects other cellular functions [120]. Our recent work showed that nuclear 
eccentricity is positively correlated with VSM tissue contractility [90]. We asked if 
nuclear shape and projected area are also suggestive of the observed differences in 
isolated VSMC contractility. We grouped isolated VSMCs into 5:1, 10:1 and 20:1 ARs 
and compared nuclear eccentricity and projected area with Tbx and KTx. Here, we found 
that as projected nuclear area increased, Tbx increased while KTx decreased significantly 
(Figure 2-20 B). However, as nuclear eccentricity increased, Tbx decreased while KTx 
decreased significantly (Figure 2-20 C). These data suggested the morphological changes 
in VSMC nucleus may be an important metric for assessing the absolute and relative 
contractile strength of VSMCs in response to external stimuli.  
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Figure 2-20: Contractile output correlated with cytoskeletal organization and 
nuclear morphology. Basal longitudinal traction force (Tbx, black) and relative 
contractile increase (KTx, red) in longitudinal traction force after ET-1 stimulation (KTx, 
red) as a function of OOP (A), projected nuclear area (B) and nuclear eccentricity (C). 
The correlation coefficient, r, is determined by linear regression analysis. Reported p 
values for Pearson correlations are two-tailed, demonstrated that the correlation is 
significantly different from zero. All plots: mean ± SEM. n = 13-18 cells per condition.  
 
2.3  Discussion 
In this study, we showed that VSMC shape can regulate its contractile function. 
We found that whereas wider width cells generate a greater force when stimulated with 
ET-1, but that longer, thinner VSMCS have a greater range of contraction relative to their 
basal tone. This suggests that where the vasculature requires a higher fidelity in its 
modulation of blood flow, longer, thinner cells are functionally advantageous.  This is 
particularly relevant to vascular tissue engineering where there is a requirement that 
vascular grafts are compatible both anatomically and functionally at the graft site [179-
181]. In the past two decades, several strategies have been explored to recapitulate the 3D 
architectural organization in native vessels [182]. Customarily these strategies rely on 69 
 
seeded cells to migrate and self-assemble into tissues with minimal guidance. While 
arterial replacements can be engineered in vitro, when engrafted, the compliance 
mismatch between the graft and native vessel results in thrombosis and intimal 
hyperplasia at the anastomotic site, resulting in low patency rate [183, 184]. Our findings 
suggest that, in addition to closely matching the biomechanical aspects of healthy artery, 
engineering vascular grafts with VSMC shapes that mimic cellular architecture of the 
native, healthy vasculatures could improve functionality and long-term patency.   
Morphology has been an important parameter in the definition of smooth muscle 
cell phenotypes, especially when protein marker data is not available [139]. Our result 
shows that individual VSMCs cultured on soft PAA gel and stiff glass substrates with 
isotropically patterned FN both exhibited a wide distribution of morphologies from 
rhomboid to spindle-like, suggesting that we may have VSMCs with both synthetic and 
contractile phenotypes present despite the effort to differentiate VSMC into contractile 
phenotype by serum starvation. A previous study demonstrated that VSMCs cultured on 
stiffer substrate composed of dehydrated collagen fibrils led to a more proliferative, 
synthetic phenotype compared to the softer hydrated collagen fibrils [185]. However, 
even on the much stiffer glass substrate, we still observed spindle-like morphology, 
highlighting the need of a combinatorial, multi-pronged approach for regulating VSMC 
phenotype that may include biochemical, mechanical, and extracellular matrix factors 
present in the cellular microenvironment. 
In addition to the variance in morphology, we also observed that individual 
VSMC spreading area is normally distributed on both PAA gel and glass substrates. This 
is consistent with results reported by Tolic-Norrelykke and colleagues [166] where they 70 
 
found the projected surface area of human aortic smooth muscle cells is normally 
distributed. This may be a result of the intrinsic diversity of VSMC in the vessel wall 
where immunohistochemical staining pattern of contractile VSMC phenotype markers 
revealed highly heterogeneous staining patterns and intensity between adjacent SMCs. 
[186, 187] This spectrum of phenotypes expressed in VSMCs has been suggested to be a 
combinatorial effect of both genetic programing and local environmental factors. [139] 
Taken together, these studies and our result suggests isotropic ECM signal would lead to 
a wide distribution of VSMC phenotype in vitro, additional structural, biochemical or 
mechanical cues are needed to homogenize the population phenotype.  
We previously reported that engineered VSM with forced elongated spindle 
shapes exerted greater contractile tensile stress when chemically stimulated [188]. The 
results reported herein are consistent with the findings by Tolic-Norrelykke and Wang, 
where they found that cells with wider width contracted with greater force than slimmer 
cells with a similar projected area [166]. The differences in observed shape-contractility 
relationship between the current findings and our previous study by Alford and 
colleagues may be attributed to differences in measured quantities, experimental 
techniques and cellular micro-environmental conditions. Our previous study utilized the 
muscular thin film technology [189-191], which measured the contractile strength of the 
VSM tissue with the component of Cauchy stress along the cell orientation. This 
measured quantity represented contractile force per tissue cross-sectional area, whereas 
the current study quantified the contractility of VSMCs via TFM, which measured the 
contractile force and strain energy exerted by the cell on the substrate. In addition, the 
engineered VSM tissue tested in Alford et al. was cultured with a higher level of cell-cell 71 
 
contact, the possibility of off axis alignment of cells, and stiffer abiotic substrates as 
compared to this single cell study. These differences in micro-environmental conditions 
will influence VSMC phenotype [102] and functions [36, 37, 192-195]. As a result, 
measured contractile strength may be reduced as it reflects an average of all cells in the 
tissue, including weakly or non-contractile cells and cells oriented in off-axis compared 
to the global orientation of the tissue.  
Tension development and generation requires F-actin network to activate 
myosin ATPase activity and cross-bridge cycling in all forms of muscles, including 
smooth muscle cells.[2] In isolated smooth muscle cells where intercellular mechanical 
couplings are absent, actin filaments anchored at focal adhesion complexes must balance 
intracellular tension by transmitting the force to the substrate. Our findings that reduced 
F-actin fiber alignment correlated with VSMCs with higher contractile strength suggest 
that higher contractile forces were bore by the less organized F-actin fibers than the 
aligned fibers. This is reasonable as an increased cell width permits more sites at the two 
ends of the cells for the formation of focal adhesion complex, which has been shown to 
play an important role in the stabilization of tension bearing F-actin fibres [196]. The 
wider cell also has more degree of freedom laterally for the F-actin fibre orientations, 
which explains the lower overall alignment. This cell shape mediated cytoskeletal 
remodelling also corroborated with our findings that decreased F-actin fibre alignment 
correlated with lower relative contractile increase and less cell shortening: a phenomenon 
that can explained by the model proposed by Seow, Ford and co-workers [197, 198] as 
actin filaments rearrange connections from a parallel fashion in shorter cells to a serial 72 
 
fashion in elongated cells. Taken together, our results suggest that cell shape dependent 
contractility changes in smooth muscle cells may be mediated by cytoskeletal modelling.  
Three possible mechanisms have been put forward to explain the F-actin fiber 
remodeling process. Gunst et al. have proposed a model that suggest cell shape 
adaptation is a result of a shift in the connection of actin filaments terminations among 
the adhesion plaques to which it may attach by modifications in length and number of 
actin filaments [199].  Seow et al. suggested a second mechanism that attributed the 
remodeling process as a parallel-to-series transition and cell elongation could lead to 
rearrangement of crossbridges or addition of thick filament in series [198, 200]. The third 
mechanism proposed by Solway et al. is a variation of second mechanism that suggested 
that systematic modulation in actin filament length is responsible for cell shape changes, 
which means cells with shorter actin filaments may undergo parallel-to-series transition 
while longer actin filament do not as cell elongates [201]. Although we did not directly 
measure for change in actin filament length, we found that relative shortening in cell’s 
long axis reduced significantly while it remained comparable in cell’s short axis as cell 
elongated, suggesting that different mechanisms may be governing the shortening process 
depending on the length of the cell’s axis. This is in support of the third mechanism 
proposed by Solway et al. as shorter actin filaments undergo parallel-to-series remodeling 
as cell shape elongates [201]. While the increase in F-actin alignment during the cell 
elongation process could be attributed to the decrease in lateral freedom in the 
orientations of actin filaments as a result of reduced cell width, a parallel-to-series 
remodeling in actin filaments may also increase the overall alignment, in support of this 73 
 
mechanism. However, to definitively test this hypothesis, measurement of individual 
polymerized F-actin fibers is needed. 
Mechanical forces exerted on the exterior of a cell are propagated into the cell 
via the cell cytoskeleton to the nuclear lamina [118, 119], directly affecting nuclear shape 
and gene transcription. While cell shape induced nucleus elongation has been well 
documented, the relative contribution between longitudinal tension and lateral 
compression imposed by the stress fibres on the nucleus is unknown [72]. Our finding 
that nuclear eccentricity negatively correlated with longitudinal traction force suggests 
that lateral compression forces exerted by stress fibres physically deforms the nucleus. 
This observation agrees with a recent report detailing how lateral compressive forces 
exerted on the nucleus are responsible for shape deformation, chromatin remodelling and 
reduced cell proliferation [120]. Others have proposed that compressive physical forces 
exerted by aligned actin fibres are required to expose transcription binding sites or DNA 
regulatory motifs, potentiating differences in DNA-associated protein binding and gene 
transcription [202]. Since nuclear shape deformation is correlated with physiological [90, 
120, 203-205] and pathological [206-209] changes in cellular functions, nuclear 
deformation may be indicative of, and further distinguish, the function and phenotype of 
vascular smooth muscle.  
In this study, we demonstrated that isolated VSMCs with elongated shape 
exhibited less contractile strength but greater relative contractile increase upon 
stimulation. This shape-dependent contractile behaviour suggests that the elongated shape 
of VSMC in muscular arteries may lead to improved dynamic contractile range, a key 
feature required for effective vascular tone modulation in vivo. In addition to providing 74 
 
mechanical insight into the physiological structure-function relationship of VSMCs, our 
finding is particularly important for obtaining the desired VSMC contractile function 
from a clinical perspective in the design of a functionally active tissue engineered 
graft.[210] Our data suggest that providing organizational guidance cues to guide the 
development and assembly of VSMC into elongated shape may be beneficial in a 
successful implantation of a small artery graft. 
 
2.4  Experimental Challenges 
Completing this section posed many experimental challenges, especially in 
regards to microfabrication of rectangular isolated VSMCs. Despite the fact that 
microcontact printing has been widely used in many groups including ours, the 
micropatterning technique used in this section uses a modified protocol in order to 
accommodate the soft PAA gel substrate, which requires drying of the PAA gel prior to 
transferring of the biotinyated FN from the PDMS micro-features. However, if the PAA 
gel is too dried, the gel will crack and even upon hydration, the substrate is no longer 
usable for subsequent micropatterning. Therefore, this step requires a careful balancing 
act that leaves only a narrow window of a few minutes drying time. To complicate this 
matter further, factors such as humidity, the amount of residue fluid on the PAA gel prior 
to drying and the thickness of the gel could all influence the optimal drying time, 
resulting a relative low rate of success in FN micropatterning and a steep learning curve 
initially. However, with more experience in experimental technique to minimize batch-to-
batch variations and careful monitoring during the drying process over time, we were 75 
 
eventually able to master the micropatterning technique and achieve a relatively high 
success rate. 
Another challenge we encountered is to ensure the isolated VSMC stay adhered 
on the micropatterned islands for immunohistochemical staining. In the early phase of the 
study, we adopted without modification the cell culturing protocol from a previously 
published study from our group on VSM tissue of the same cell type [90]. This protocol 
specifies a 2-day culture post seeding in 10% FBS containing media followed by a 1-day 
serum free starvation period to induce the contractile phenotype of the VSMC. However, 
we discovered that this protocol did not work well for our study because: (1) the initial 2-
day culture in 10% FBS media led to a significant proliferation of seeded VSMCs which 
caused most of the islands to be occupied by more than 1 single cell as visible during the 
DAPI immunohistochemical staining (data not shown) and (2) the 1-day serum starvation 
period was not long enough to fully induce the contractile phenotype uniformly among 
the microfabricated isolated VSMCs as initial assessment of micropatterned VSMC 
projected surface area showed a wide distribution, suggesting that not all cells have 
reached their equilibrium contracted state. One plausible explanation for this discrepancy 
maybe that when cell-cell contact is present in the case of VSM tissues in previous study, 
contractile phenotype is more quickly established [211]. However, in the case of isolated 
VSMCs, contractile phenotype establishes more slowly as only biochemical cue is 
present in the cellular microenvironment. We addressed these issues simultaneously by 
decreasing the post-seeding 10% FBS serum culturing period from 2 days to 1 day and 
lengthening the subsequent serum starvation from 1 day to 2 days. Following the 
implementation of this protocol, we obtained a higher percentage of single celled islands 76 
 
by day 3 with uniform projected surface area for all ARs, suggesting a more uniform 
phenotype expression. 
One major challenge involved with live cell imaging is the possibility of 
phototoxicity induced by the reactive oxygen species (ROS) generated from ambient and 
laser light exposures [212]. In order to monitor how isolated VSMC contractility 
responds to different vasoactive agents, we needed to image the cells for over 1 hour 
under the confocal microscope for TFM studies. This is much longer than conventional 
TFM studies for cardiomyocytes commonly done in our group, where a typical imaging 
cycle lasted only a few seconds. As a result, the repeated laser and ambient light 
exposures over the course of TFM led to VSMC phototoxicity in the form of cell 
blebbing, necrosis, and eventual delamination from the substrate. To address this issue, 
we increased the imaging interval from 1 minute to 4 minutes and also reduced the laser 
and ambient light power to the minimal level that could still be used for TFM analysis. 
While we lost temporal resolution for VSMC contractile kinetics, we were still able to 
measure the equilibrium contractile state achieved when stimulated with different 
vasoactive agents. With reduced imaging interval and light power greatly, most of the 
VSMCs imaged no longer present any signs of phototoxicity and the small percentages of 
VSMCs that did were excluded from subsequent analysis.  
 
2.5  Methods and Materials 
2.5.1  Sample Preparation 
2.5.1.1  Photolithography 77 
 
Photolithographic chromium mask for microcontact printing were designed in 
AutoCAD (Autodesk Inc.) and fabricated at the Center for Nanoscale Systems facility 
with Heidelberg DWL-66 mask writer. The design for traction force microscopy (TFM) 
studies, consisted of rectangles of approximately 4,000 µm2 surface area and variable 
length to width ratios (5:1, 141 µm x 28 µm; 10:1, 200 µm x 20 µm; 20:1, 280 µm x 14 
µm). Silicon wafers (Wafer World) spin-coated with SU-8 2002 negative photoresist 
(MicroChem Corp.) were exposed to ultra-violet (UV) light to cross-link the designed 
pattern. Uncross-linked regions were dissolved by submerging the wafers in propylene 
glycol methyl ether acetate. 
 
2.5.1.2  Microcontact Printing of Polyacrylamide Gels 
ECM protein FN after biotinylation modification was microcontact printed onto 
the polyacrylamide (PAA) substrate, as previous published.4 Briefly, FN was cross-linked 
with biotin using Sulfo-NHS-LC-Biotin (Pierce). 13 kPa PAA gel substrate was 
fabricated with 5/0.1% acrylamide/bis concentration. Immediately prior to gel 
polymerization, streptavidin-acrylamide and 200 nm fluorescent beads were added to the 
gel solution for a final concentration of 1:5 and 1:100, respectively, by volume. 15 µL of 
gel-bead solution was cured on activated 25 mm coverslips. 200 µg/mL biotinylated 
fibronectin (biotin-FN) was incubated on a PDMS (Sylgard 184, Dow Corning, Midland, 
MI) stamp with microscaled raised features for 1 h at room temperature and blown dry 
gently. The biotin-FN coated PDMS stamp was placed in contact with cured PAA gel, 
transferring the biotin-FN pattern to the substrate. The patterned PAA gel was stored in 78 
 
phosphate buffered saline (PBS) until cell seeding. When seeded, cells were constrained 
to the ECM patterned portion of the substrate after serum starvation.  
 
2.5.2  Human Umbilical Arterial Smooth Muscle Cell Culture 
Human umbilical artery smooth muscle cells (Lonza, Walkersville, MD) 
purchased at passage 3 was cultured in growth medium consisted of M199 culture 
medium (GIBCO, Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(FBS, Invitrogen), 10 mM HEPES (GIBCO, Invitrogen, Carlsbad, CA), 3.5 g L-1 glucose, 
2 mg L-1 vitamin B-12, 50 U mL-1 penicillin and 50 U mL-1 streptomycin (GIBCO). All 
experiments were performed at passage 6-7.  
VSMCs were seeded in growth media at 5,000 cells cm-2 and allowed to attach 
to the isotropically patterned FN on PAA gel or patterned biotin-FN islands on PAA gel 
for 24 hours before replaced with a growth factor free medium consisted of M199, 10 
mM HEPES, 3.5 g L-1 glucose, 2 mg L-1 vitamin B-12, 50 U mL-1 penicillin and 50 U 
mL-1 streptomycin to induce a contractile phenotype for 48 hours prior to cell staining or 
TFM experiments. 
 
2.5.3  Fluorescent and Immunohistochemical Staining 
VSMCs seeded on PAA gel after 3 d of culture were fixed with 4% 
formaldehyde solution (Thermo Scientific Pierce) for 10 minutes prior to staining. 
VSMCs seeded on isotropically patterned FN were stained for cell membrane (DiO, 
Invitrogen) and nucleus (DAPI) while VSMCs seeded on patterned biotin-FN islands 
were stained for F-actin (phalloidin, Molecular Probes) and nucleus (DAPI). Patterned 79 
 
FN islands were stained with rabbit anti-human fibronectin antibody (1:100 dilution, 
Sigma-Aldrich, St. Louis, MO) followed by Alexa Fluor 647 conjugated anti-rabbit 
secondary antibody (1:100 dilution, Abcam). The stained samples were then mounted 
with ProLong Gold antifade agent (Molecular Probes) and stored in -20°C freezer until 
imaging. 
 
2.5.4  Cell, F-actin, and Nucleus Image Analysis 
The spreading area of single cells on isotropically patterned FN was manually 
traced in ImageJ (rsbweb.nih.gov/ij/) and quantified. Cell AR was calculated by manually 
tracing the phalloidin stain in ImageJ. F-actin OOP was calculated from phalloidin stain 
with a coherence threshold of 0.3 using a structure tensor method.[170] Cell thickness 
was calculated from deconvolved Z-stack images of F-actin from Imaris. Nuclear angle 
offset (θ) was calculated by manually tracing the outlines of nucleus and cell body in 
ImageJ and comparing orientation difference between the principle axes. Nuclear 
eccentricity was evaluated by fitting an ellipse to individually traced nucleus in ImageJ 
and calculating its eccentricity, defined as: 
        e = √1 − (
minor axis length
major axis length)
2
         (1) 
Projected nuclear area was quantified by tracing the outline of the nucleus in 
ImageJ. Nuclear surface area and volume were evaluated by fitting an ellipsoid with half-
length (a), half-width (b) and half-height (c) to each individual nucleus from deconvolved 
z-stack images in Imaris (Figure 2-11 A) with the following formulas: 
        ? =  𝜋
4
3???               (2) 80 
 
        ?𝐴 ≈ 4𝜋(
?𝑝?𝑝+?𝑝?𝑝+?𝑝?𝑝
3 )
1 𝑝 ⁄
         (3) 
where p = 1.6075. Cell shortening was calculated by summing the differences in cell 
length from DIC images of cell at basal and relaxed conditions (Figure 2-19 A). OOP, 
nuclear angle offset, eccentricity, projected area, surface area, and volume were 
quantified from between 7-12 images of isolated VSMCs for each AR. All results were 
compared using ANOVA on ranks test, with pairwise comparisons performed using the 
Tukey’s test. All correlations analysis was evaluated using Pearson product moment 
analysis. 
 
2.5.5  Cell, Patterned Fibronectin Island, F-actin and Nucleus Fluorescent 
Microscopy 
Fixed and stained cells seeded on isotropically patterned FN were imaged on a 
line-scanning Zeiss LSM 5 LIVE confocal microscope (Carl Zeiss, Oberkochen, GER) 
with a 20x Plan-Apochromat objective at 1x zoom and laser excitations at 405 nm and 
488 nm wavelengths to image the DAPI and DiO staining respectively. With the same 
microscope, stained micropatterned FN islands on PAA gel were imaged with a 20x Plan-
Apochromat objective at 0.5x zoom and laser excitation at 633 nm wavelength. 2D and 
Z-stack images of phalloidin stained F-actin and DAPI stained nucleus were acquired 
with the Zeiss LSM 5 LIVE confocal microscopy with a 40x EC-Plan Neofluar lens oil 
objective with 1x zoom and laser excitations at 561 nm and 405 nm wavelength 
respectively. Z-stack images were subsequently deconvolved in Imaris (Bitplane 
Scientific Software).  
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2.5.6  Traction Force Microscopy Experiment 
After 3 d of culture, micropatterned VSMCs on PAA gels were moved to an 
incubation chamber on a Zeiss LSM 5 LIVE confocal microscope maintained at 37ºC and 
immersed in Tyrode’s solution (1.8 mM CaCl2, 5 mM HEPES, 1 mM MgCl2, 5.4 mM 
KCl, 135 mM NaCl, 0.33 mM NaH2PO4, adjusted to pH 7.4). After allowing the cells to 
equilibrate for 10 minutes in the incubation chamber, isolated VSMCs were imaged with 
a 40x EC Plan-Neofluar oil objective at 0.5x zoom on a Zeiss LSM 5 LIVE confocal 
microscope (Carl Zeiss, Oberkochen, GER) 3 times every 4 minutes with both bright 
field and 488 nm wavelength laser excitation to obtain images of VSMCs baseline 
contracting and displacing fluorescent beads in the gel substrate. Subsequently, the 
VSMCs were imaged 3 times every 4 minutes after stimulation with 100 nM ET-1 for 15 
minutes, followed by 100 µM HA-1077 (Sigma-Aldrich, St. Louis, MO) for 15 minutes. 
During the stimulation, no images were taken to minimize the amount of photo-damage 
to cells. Immediately prior to cell detachment, cell nuclei were stained with DAPI and 
imaged to ensure that only single cells were analysed. At last, trypsin was added to 
detach the cells from the substrate. The experiment was terminated when the cell in the 
field of vide dissociated from the gel, thus leaving the gel with no surface traction. 
 
2.5.7  Traction Force Microscopy Data Analysis 
Displacement and traction stress vectors were calculated from the bead 
displacement as previously published [174]. Briefly, displacement of gel was determined 
by comparing the beads images at baseline, stimulated and relaxed states to the bead 
image when cells were detached from the substrate. The traction stress field was then 82 
 
calculated from the displacement map using Fourier transform traction cytometry method. 
Traction stress vectors were discretized to a 10 x 10 µm2 grid.  
To calculate the total strain energy U transferred from the cell to the elastic 
distortion of the substrate, we applied the following equation as previously published [89]:  
      ? =
1
2∑ 𝐴𝑛(??,𝑛??,𝑛 + ??,𝑛??,𝑛) 𝑛                          (4) 
where ?𝑖 and ?𝑖 represent displacement and traction force vectors in the i-direction; A is 
the discretized unit surface area of the cell body.  
To calculate the total traction force cell ?𝑖 applied to the substrate in the i-
direction, we summing the magnitudes of all traction force vectors ? ⃑ 𝑖,𝑛 cell exerted on 
both sides and multiply by one half as previously published [89]:  
        ?𝑖 = 
1
2∑ 𝐴𝑛|? ⃑ 𝑖,𝑛| 𝑛                      (5) 
assuming that cells exerted about equal magnitude of traction force at each sides.  
  To calculate the longitudinal cumulative cellular prestress Px, we divided the total 
traction force in the longitudinal direction Tx by the averaged cross-sectional area of the 
cells.  
Isolated VSMC AR was calculated in ImageJ by tracing the cell outline from a 
DIC image taken at baseline. VSMCs that responded to ET-1 stimulation with 
significantly elevated strain energy were selected for correlation analysis. All correlations 
analysis was evaluated using Pearson product moment analysis.   
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3  Engineering Vascularized Network in Folded, Porous 
Polymer Matrices by Tissue Origami 
Organ function relies on hierarchical organization within tissues from single 
cells (~10 µm) to functional subunit (100 µm – 1 mm). Traditional tissue engineering 
scaffolds typically use a porous structure made of synthetic or natural polymer, which 
provide little control in organizing cells into three-dimensional structures. The lack of 
cellular architecture contributes to suboptimal tissue function. We present a simple and 
versatile scaffold folding strategy, Tissue Origami, which allows organization of multiple 
cell populations within three-dimensional, porous, synthetic and natural polymer matrices. 
We demonstrated that individual layer of porous, sub-millimeter thickness poly(lactic-co-
glycolic) acid and collagen films patterned with multiple cell populations can be folded in 
Miura-ori geometry to produce different three-dimensional cellular organization within 
the engineered construct. We found patterned cells were healthy and viable in the folded 
construct and were metabolically active 3 days after seeding. In a proof-of-concept study, 
we patterned endothelial and smooth muscle cells with different three-dimensional 
configurations in the folded constructs to build vascularized network and compare them 
to the traditional bulk, porous polymer matrices. We quantified the number of blood 
vessels formed within each construct systematically and found that the folded constructs 
seeded with endothelial cells and vascular smooth muscle cells adjacent to each other 
laterally in the same folding plane created the densest vascularized network. This 
technique may enable development of organized vascular tissues that closer mimic native 
tissues and improve the function of engineered tissues.  
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3.1  Introduction 
Tissue engineered construct is typically assembled through the combination of 
cells and biomaterials in hope that it would replace damaged or diseased organs. 
Traditional porous polymer scaffold are designed to support the attachment and 
proliferation of cells, in order for them to recapitulate lost tissue functions [213]. These 
cells are influenced not only by autonomous programs but also by their cellular micro-
environment, which include interaction with neighboring cells, biochemical factors and 
physical forces. The collective effect of these factors depends on the hierarchical 
organization among the tissue construct. However, due to lack of control over cell 
seeding process in three-dimensional  polymer matrices, the resultant tissue engineered 
construct has little organization to its tissue architecture. In contrast, tissues in native 
environment consist of highly organized smaller repeating unit on the scale of hundreds 
of microns (e.g. muscle tissue, islet, nephron) that interacts with neighboring cells and 
performance specific functions [214]. This difference in microarchitecture leads to 
suboptimal functions for tissue engineered construct and hindered the advancement of 
this field in achieving clinically relevant organ replacement products.  
Over the last decade, a number of promising techniques have emerged to 
address the lack of control in cellular organization for tissue engineered constructs. 
Several of these techniques has demonstrated the ability to produce tissue constructs with 
cellular organizations including 3D inkjet bioprinting [215, 216], layer-by-layer cell sheet 
stacking [217, 218], spheroid self-assembly [215] and laser guided direct writing [219]. 
These techniques largely rely on recent advancement in rapid prototyping technology to 
assemble miniaturized modular units with different cell types to achieve structure 85 
 
organization within tissues. Although these techniques successfully patterned cells in 3D 
to a varying extent, there is some critical drawback associated with them that prohibited 
wide adoption of these techniques in clinically settings. For example, the 3D inkjet 
printing technique is restricted to using only hydrogel as cell carrier, tissue spheroid 
technique requires specialized equipment, and cell sheet stacking and laser guided direct 
writing have low throughput due to lengthy operations.  
We developed a strategy to engineer vascularized networks in three-dimensional, 
porous, polymer matrices by folding synthetic and natural polymer films with patterned 
vascular cells. We fabricated poly(lactic-co-glycolic) acid (PLGA) and collagen thin 
films and folded them into Miura-ori geometry along laser-etched perforated lines. We 
patterned human endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) on 
thin films by loading them onto acrylic posts of a stamping system and subsequently 
inverting the posts to transfer the cell suspensions at pre-defined locations on the films. 
The patterned cells were viable in the folded polymer matrices 3 days after seeding. We 
built vascularized networks by patterning ECs and VSMCs in different three-dimensional 
organizations in the folded polymer matrices and found that organization with patterned 
ECs and VSMCs on the same folding plane had a significantly higher vessel density 
compared to the folded configuration that homogenously mixed the two cell types. These 
findings suggest that three-dimensional organized structure of vascular cells may lead 
improved vascularization potential in porous polymer matrices.   
 
3.2  Results 
3.2.1  Fabrication and Visualization of Thin, Porous PLGA film 86 
 
We hypothesized that thin and porous films can facilitate the manual folding 
process and increase nutrient transport for cell survival within the construct. We adapted 
published solvent casting and porogen leaching methods to fabricate the PLGA film 
(Figure 3-1 A). Briefly, a glass plate enclosed by 4 glass slides near the edges formed a 
well for the solvent cast. Since PLGA film adhered strongly to glass (data not shown), we 
pre-coated our glass plate with 2% w/v alginate solution as a sacrificial layer that 
facilitates the removal of PLGA film at a later time. Sugar particles that were sieved 
between 90 to 106 µm served as porogen for creating a porous architecture. The amount 
of sugar particles was calculated to produce a 90% porous structure after leaching. 
Immediately after adding the sugar particles to the 5% w/v PLGA in chloroform solution, 
the mixture was casted into the well coated with alginate to uniformly spread the sugar 
particle. When the chloroform solution evaporated from the casted mixture, the entire 
construct was placed in a desiccator overnight to completely remove any residue solvent. 
The PLGA thin film was obtained by placing the construct in DiH2O for 4 hours to 
dissolve the embedded sugar particles and the alginate thin film, allowing the PLGA film 
to float to the surface.  
The dried PLGA film was flexible and uniform, with no structural defect (Figure 
3-1 B). Due to the highly porous nature of the film, it appeared to be translucent. The 
thickness of the PLGA film was 280 ± 20 µm (mean±SD), suggesting that the film 
contains, 2-3 layers of sugar particles prior to water leaching on average. Scanning 
electron microscopy (SEM) images showed a highly porous and interconnected micro-
structure, with some large pores passing through the entire film (Figure 3-1 C). Higher 
magnification images demonstrated that in addition to large pores around the size of 87 
 
sugar porogen, pores between 100 nm and 3 µm are also scattered throughout the film 
structure (Figure 3-1 D-E). Taken together, we created a highly porous, reproducible, 
flexible PLGA thin film with sub-millimeter thickness. 
 
Figure 3-1: PLGA film fabrication and visualization. (A) PLGA (75:25) porous and 
thin film was fabricated by using solvent casting and porogen leaching method. (B) 
Flexible, translucent PLGA porous thin film obtained with an average film thickness of 
280 ± 20 µm (mean ± SD). SEM image of porous PLGA thin film viewed under low (C), 
med (D) and high (E) magnifications. The scale bars in (C-E) are 500, 50 and 5 µm 
respectively. Some pores penetrated all the way through the scaffold as evident in (C, 
white arrowheads).   
  
3.2.2  Fabrication and Visualization of Thin, Porous Collagen Film 
Since collagen is not dissolvable in organic solvent, we modified the protocol 
from a published patent and fabricated the collagen thin film through a freeze-drying 
method (Figure 3-2 A) [220]. Briefly, we dissolved the collagen powder in 0.05 M glacial 
acetic acid and blended the mixture with a commercial blender to obtain a uniform 88 
 
mixture of slurry. After deforming the mixture by centrifugation, the collagen slurry was 
sandwiched between two glass plates enclosed with four Teflon tape spacers and froze in 
-20°C freezer. After transferring the construct to the -80°C freezer for an additional 24 
hours, the construct was lyophilized for 48 hours, leaving only the porous thin film 
behind. The finished collagen film is flexible and thin, with a white appearance (Figure 3-
2 B). We measured the thickness of the film to be 286 ± 14 µm (mean ± SD), suggesting 
that the inter-batch thickness variation is minimal. We examined the microstructure of the 
film via SEM and found a highly porous architecture with similarly sized pores (Figure 3-
2 C). High magnification images showed no nano-sized pores as seen in the PLGA thin 
film (Figure 3-2 D-E).  
 
Figure 3-2: Collagen film fabrication and visualization. (A) Porous, thin collagen film 
was made by freeze-drying blended collagen slurry. (B) Collagen thin film obtained with 
an average film thickness of 286 ± 14 µm (mean ± SD). SEM image of porous PLGA 
thin film viewed under low (C), med (D) and high (E) magnifications. The scale bars in 
(C-E) are 200, 100 and 50 µm respectively.    89 
 
Since collagen can be degraded by enzymes such as collagenase and pepsin in 
vivo, we characterized the degradation behavior of the fabricated collagen thin film by 
calculating the weight remained (wr) in phosphate-buffered saline (PBS) with and without 
collagenase as a fraction of initial weight (w0) after specific time periods. We found that 
in PBS without the collagenase, the weight fraction (wr/w0) dropped significantly after 24 
hours but remained similar thereafter until the end of the experiment 7 days later (Figure 
3-3). However, degradation of collagen thin sheet was significantly faster in PBS 
containing collagenase at 100 µg/mL. At the end of the experiment 2 hours later, only 40% 
of the initial weight remained and the weight-time function was approximately linear 
(Figure 3-3). Taken together, the degradation profile of collagen thin film suggests that 
long term culture of cells that are capable of degrading collagen may compromise the 
structural integrity of the thin film and cross-linking of the collagen may be required prior 
to long term cell culture.  
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Figure 3-3: Degradation profiles of collagen thin film in PBS and collagenase. The 
weight fractions were calculated as the ratio between the weight remained (wr) after 
immersing in PBS with ( ) or without ( ) collagenase at 100 µg/mL at 37°C to the 
initial weight of the thin films (w0). The degradation behavior in collagenase can be 
approximated linearly with the equation: 𝑤𝑟 𝑤0 = −8.33 × 10−5? + 0.949 ⁄  with R2 = 
0.976. Data ± SEM. n = 3 for each condition. 
 
3.2.3  Folding Thin Film into Miura-geometry with Laser-etched Perforated 
Lines 
We selected the Miura-geometry invented by Japanese astrophysicists Koryo 
Miura to fold our thin film construct because this particular geometry allows for packing 
of the thin sheet into a very compact area with its thickness restricted only by the 
thickness of the thin sheet itself. To improve the fidelity and reproducibility of manual 
folding, we designed the folding lines of the Miura-geometry in a computer-aided design 91 
 
(CAD) program and laser-etched periodical perforations along the design on porous 
PLGA (Figure 3-4 A) and collagen (Figure 3-4 B) thin sheet prior to folding. The outer 
boundary of the Miura-geometry was produced by using higher laser power to completely 
sever the thin film. The etched lines allow for folding of PLGA (Figure 3-4 C) and 
collagen (Figure 3-4 D) thin films easily and subsequent retaining of folded geometries 
without external constrains. This approach allowed us to fold PLGA and collagen thin 
sheet into Miura-geometry manually easily and precisely.  
 
Figure 3-4: Folding of laser-etched PLGA and collagen thin film into the Miura-ori 
geometry. PLGA (A) and collagen (B) thin films with an 8-facet Miura-geometry. The 
perforated folding lines were laser-etched from a user-designed CAD drawing. 3D 16-
facet PLGA (C) and 8-facet collagen (D) folded constructs were obtained by manually 
folding along the perforated lines. (A-B) scale bars = 1 cm.  92 
 
 
3.2.4  Patterning of Thin Films with Post-stamping System 
We developed a two parts post-stamping system to pattern the thin films at user-
defined locations with liquid droplets (Figure 3-5 A). Prior to patterning the film, liquid 
droplets were loaded onto each individual acrylic posts on the stamping system. The 
posts with liquid droplets were then inverted upside down and pressed gently to allow the 
liquid droplets to transfer into the thin film.  
The top part is made of acrylic plate with small acrylic posts of equal height 
fixed at various locations (Figure 3-5 B). The acrylic posts were fabricated by cutting out 
circular holes on a 1/8” thickness acrylic plate with laser at high power. The locations of 
the acrylic posts were designed in a CAD drawing such that the pattern these posts 
created on a two-dimensional thin sheet aligns along the z-axis when the film folds into 
the three-dimensional Miura-ori geometry. Low power laser was used to lightly mark the 
locations on the acrylic top plate and premade acrylic posts were subsequently glued at 
these locations.  
The bottom part is made of two 1/8” thickness acrylic plates glued together 
where one plate had the center region shaped of the outer boundary of 2D Miura-
geometry completely removed by laser (Figure 3-5 C). This hollowed center region 
served as the loading location for the thin film that needs to be patterned. Four 1” screws 
were machined into the four corners of the bottom part with the corresponding screw 
holes on the top part to fix the xy-plane position during the patterning process. When the 
top and bottom parts are assembled, four nuts were used to equalize and stabilize the 
downward pressure exerted on the enclosed thin film by the acrylic posts (Figure 3-5 D).  93 
 
We stamped green and red liquid food coloring droplets on PLGA thin films to 
produce the alternating coloring pattern (Figure 3-5 E). We found that the patterned shape 
of the liquid droplet was not circular of the post and there was liquid bleeding underneath 
the film (Figure 3-5 F).  
 
Figure 3-5: Patterning PLGA thin films with post-stamping system. (A) Schematics 
illustrating the stamping process. (B) The top part is composed of acrylic posts bonded to 
a base acrylic plate at specific locations in the faces of the Miura-geometry such that the 
patterned locations aligns vertically in the z-axis of the folded thin film. Scale bar = 1 cm. 
(C) The base part is created by bonding two acrylic plates together with the center region 
of one of the plates pre-cut in the shape of the Miura-geometry. The translucent regions 
were the dried adhesive. Four screws are machined into the bottom part at the four 
corners. Scale bar = 3 cm. (D) Assembled top and bottom parts with four nuts to secure 
the stamping system. Scale bar = 3 cm. (E) Two different colored liquid droplets were 
loaded on the posts to produce the alternating pattern in PLGA thin film. Scale bar = 1 
cm. (F) Patterned droplet had a non-circular shape and liquid bleeding underneath the 
film were visible. Scale bar = 1cm.     
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To address this issue, we controlled the liquid spreading pattern in the thin film 
by creating circular laser-etched boundaries in the thin film at the stamping locations of 
liquid droplet (Figure 3-6 A). The boundaries served as a physical barrier preventing the 
liquid from spreading beyond the etched region into the main body of the thin film. 
However, when an excessive laser power was used, the etched center region detached 
from the thin film, leaving a hole behind (Figure 3-6 A, black arrowheads). With 
different food coloring diluted in DiH2O, we created circular liquid dots of different sizes 
simultaneously in the PLGA thin films (Figure 3-6 B). By designing different post and 
color loading configurations, we created two patterns in the film: alternating colors of 
same-sized dots along the z-axis (Figure 3-6 C) and different-sized dots on the same xy-
plane (Figure 3-6 D). As a result of the physical boundary, the resolution of circular dots 
increased to about 1 mm in diameter. Immediately after liquid droplet stamping, the film 
was folded along the laser-etched perforated lines into the 3D Miura-geometry construct.  
We evaluated the efficiency of the post-stamping system in patterning collagen 
thin films. 3µL of food coloring droplets containing 1% w/v gelatin/DiH2O were 
individually dispensed on the posts before brought into contact with the collagen thin 
film (Figure 3-7 A: top view, Figure 3-7 B: side view). Although most of the liquid dots 
were constricted within the physical boundaries, in some cases, the droplet was able to 
wet into the main body of the thin film, leaving a blot extending beyond the physical 
boundary (Figure 3-7 C). We suspected that this may be due to increased hydrophilicity 
of collagen.The patterned collagen thin film folded easily into the final 3D Miura-
geometry construct (Figure 3-7 D). Taken together, the post-stamping system combined 95 
 
with the laser-etched boundary allow for simultaneous patterning of different sized liquid 
dots on PLGA and collagen thin films at user-defined locations.  
 
Figure 3-6: Laser-etched circular boundaries improved patterning fidelity and 
consistency in PLGA thin films. (A) Laser-etched circular boundaries in a PLGA thin 
film. Excessive laser power could sever the patterned region, leaving only holes on the 
thin film (black arrowhead). Scale bar = 1 cm. (B) Red and green coloring dots in DiH2O 
enclosed with different sizes of laser-etched boundaries. The large dot was created with 3 
µL of stamping volume while the smaller dots was created with 1.5 µL. Scale bar = 1 mm. 
(C) Alternating colors of same sized dots along the z-axis of a 8-facet semi-folded Miura-
geometry PLGA construct. (D) Different sized dots could be simultaneously stamped on 
the same xy-plane of a 8-facet semi-folded PLGA construct.     96 
 
 
Figure 3-7: Laser-etched boundaries were ineffective for patterning in collagen thin 
film. Top view (A) and side view (B) of an inverted post-stamping system loaded with 
blue food coloring droplets in 1% w/v gelatin/DiH2O. (C) Collagen thin film after post-
stamping. There was liquid bleeding outside of the laser-etched boundaries, possibly due 
to hydrophilic wicking effect of collagen. (D) Semi-folded collagen thin film with the 
patterned area aligning along the z-axis. (A-D) Scale bars = 1 cm.  
 
3.2.5  Three-dimensional Cell Patterning in Folded, Porous Polymer Matrices 
In order to pattern cells in the thin films, we suspended cell in a mixture of 
media and Matrigel as previously described [221]. Since Matrigel retains its fluidity at 
4°C but polymerize into a gel at 37°C, we prepared the cell mixture with cold media and 97 
 
Matrigel at 4°C and incubated the patterned cell suspension at 37°C to allow Matrigel to 
encapsulate the stamped cells at patterned locations. To inspect the fidelity of cell pattern, 
we stained two cell populations with membrane dyes DiI and DiO that excite at 549 nm 
and 484 nm respectively. We tested different patterns for PLGA and collagen thin films. 
For PLGA thin film, we loaded the cell suspensions on 4 posts configured in an 
equilateral triangle such that the three vertices are stamped with the DiI-stained cells 
while the centroid of the triangle is stamped with the DiO-stained cells (Figure 3-8 A). 
For collagen thin film, we loaded cells stained with the same membrane dye on the 
opposing corners of a square.  
We found patterned cell populations retained its circular shape and relative 
positions to each other 2 hours after the stamping in a 2-facet folded PLGA construct 
(Figure 3-8 B). Stamping was completed with high fidelity as there was little defect in the 
shape and DAPI-stained nuclei were presented throughout the stamping area and within 
the laser-etched boundaries. However, in 2-facet folded collagen construct, the patterned 
cell populations were not as uniform as the PLGA thin film within the boundaries and 
there were signs of wicking in between the boundaries (Figure 3-8 C). Taken together, 
these data demonstrated that patterning of multiple cell populations simultaneously on 
PLGA and collagen thin films can be achieved using post-stamping system with Matrigel 
as a cell suspension carrier. However, further improvement need to be made to collagen 
thin films to achieve higher fidelity.  98 
 
 
Figure 3-8: Patterning cells in PLGA and collagen thin films using post-stamping 
system. (A) Human endothelial cells stained with DiI and DiO were suspended in 1:1 v/v 
media/Matrigel and loaded onto posts before brought into the contact with the thin films. 
Matrigel was allowed to gel at 37°C to encapsulate the patterned the cells before media 
was supplied to the folded constructs. (B) Immunofluorescent confocal images of DiI and 
DiO stained cells with DAPI counterstain near the center of a folded, two-facet folded, 
porous PLGA matrices 2 hours after stamping. The stamping pattern is an equilateral 
triangle with its three vertices stamped with cells stained with DiI and its centroid 
stamped with cells stained with DiO. (C) Immunofluorescent confocal images of DiI and 
DiO stained cells with DAPI counterstain in a folded, two-facet folded, porous collagen 
matrices 2 hours after stamping. The stamping pattern is a square with the opposing 99 
 
Figure 3-8 (Continued) vertices stamped with cells stained with the same membrane dye. 
(B-C): Dashed lines indicate laser-etched boundaries for stamping. Scale bars = 500 µm. 
 
3.2.6  Patterned Cell Viability in Folded, Porous PLGA Matrices 
We asked if the patterned cells are viable in the folded PLGA construct. We 
qualitatively evaluated the viability of human endothelial cells (EC) 2 hours after 
patterning with live/dead cell viability assay. We found that most of the cells in the 
patterned region were live (Figure 3-9 A) with minimal number of dead cells (Figure 3-9 
B). There were no cells found in yellow, indicating an absence of active cellular 
apoptosis (Figure 3-9 C). For longer culture period, we quantitatively evaluated the 
viability of human ECs and VSMCs in bulk porous PLGA matrices (Bp) and 4-facet 
folded 3D PLGA constructs (Figure 3-9 D) using alamarBlue assay. The three-
dimensional cellular organization of folded construct were divided into three categories: 
(Fs) folded PLGA matrices patterned with only ECs, VSMCs or a homogenously mixed 
population of ECs and VSMCs, (Fz) folded PLGA matrices patterned with alternating EC 
and VSMC populations along the z-axis and (Fxy) folded PLGA matrices patterned with 
both EC and VSMC populations on each facet in the same xy-folding plane arranged as 
shown (Figure 3-9 D). Each facet of the fold was stamped with 3×105 cells for a total of 
1.2 million cells per construct. After 3 days of culture, we found that the metabolic 
activities indicated by the fluorescent readings for all conditions were similar for different 
three-dimensional cellular organizations (Figure 3-9 E), suggesting a comparable level of 
live cells for all organizations. Taken together, these results suggest that the cells 100 
 
patterned in the folded PLGA matrices were able to survive after 3 days of culture in 
vitro.   
 
Figure 3-9: Cell viability evaluation in folded and bulk porous PLGA polymer 
matrices. Fluorescent images of live (A) and dead (B) human endothelial cells stained 
with calcium AM and ethidium homodimer-1, respectively, in a 4-facet folded PLGA 
tissue construct. (C) Composite image of live and dead cells in (A) and (B). (A-C) Scale 
bars = 300 µm. Live: green. Dead: red. (D) Three-dimensional cross-sectional schematic 
representations of cellular organizations with ECs, VSMCs, or homogeneously mixed 
population of ECs and VSMCs in bulk, porous PLGA matrices (Bp) and 4-facet folded 101 
 
Figure 3-9 (Continued) 3D PLGA matrices (Fs, Fz and Fxy) for metabolic assay. L1-L4 are 
folded facet of the polymer matrices. (E) Fluorescent readings as a result of the metabolic 
activities of seeded and patterned cells in bulk and folded PLGA constructs with 
background reading subtracted. Data ± SEM. n = 3 for each condition.  
 
3.2.7  Organized Three-dimensional Organization Promotes Vascularized 
Network Formation  
Angiogenesis in native environment requires EC and VSMC work in concert 
spatiotemporally [222-224]. We asked if organized three-dimensional structures of EC 
and VSMC populations patterned in folded PLGA constructs improve vascularized 
network formation in vivo. To that ends, we subcutaneously implanted EC and SMC 
organized in porous PLGA matrices with Bp, Fs, Fz and Fxy configurations on the dorsal 
regions of SCID/bg male mice (Figure 3-10 A). After 2 weeks, the constructs were 
explanted (Figure 3-10 B), imbedded in paraffin, sectioned and immunostained for blood 
vessels.  
We followed a systematic approach in quantifying the vessel density by imaging 
36 fields of views for each stained section (Figure 3-10 C). Immunostained blood vessels 
of various sizes were found in the bulk porous scaffold and folded constructs (Figure 3-
10 D) with perfused red blood cells visible in some vessels (Figure 3-10 E). We manually 
counted the number of human-caldemons positive blood vessels from the images and 
normalized by the field of view surface area. We found a significantly higher blood 
vessel density in the folded construct with Fxy configuration compared to folded 
constructs with Fs configuration (Figure 3-10 F), suggesting that organized three-102 
 
dimensional structures of ECs and VSMCs in PLGA matrices can improve the formation 
of mature blood vessels.  
 
Figure 3-10: Evaluating vascularization network formation in folded and bulk 
porous PLGA matrices. (A) PLGA bulk porous scaffold (Bp), 4-facet folded construct 
in Miura geometry with homogenously mixed human EC and SMC populations (Fs), with 
alternating EC and VSMC populations in the z-axis of the construct (Fz), and with both 
EC and VSMC populations on the same xy-plane of each facet of the construct arranged 
as shown (Fxy) were cultured for 3 days in vitro prior to subcutaneous dorsal implantation 
in SCID/bg male mice. (B) An example of explanted folded scaffold after 14 days of in 
vivo implantation.  Scale bar = 5 mm. (C) Each sectioned paraffin slide was 
systematically divided into a grid of 6 x 6 field of views (black squares, not to scale) and 
imaged. (D) Representative immunohistochemical staining of blood vessels on a 
sectioned slide. (E) Representative staining of perfused blood vessels with red blood cells. 
(D-E): (Green: anti-human CD31, Red: anti-human Caldesmon, Blue: DAPI). Scale bars 103 
 
Figure 3-10 (Continued) = 50 µm. (F) Human Caldesmon positive vessel density found 
for different three-dimensional organizations. Mean ± SEM. n = 3 explants.  
 
 
3.3  Discussion 
In this study, we developed a novel 3D cell patterning method, Tissue Origami, 
to organize multiple cell populations in 3D synthetic and natural polymer scaffolds by 
folding cell-laden 2D polymer thin films with Miura-geometry. We found cell 
populations could be patterned simultaneously with sub-millimeter resolution and 
maintained metabolically within the constructs. This is particularly relevant to the field of 
tissue engineering where cell organization in 3D scaffold could lead to improved function 
of the engineered tissue [225]. Although a number of strategies to address this issue have 
been reported in the past two decades, a large number of these studies rely on hydrogel as 
cell carrier and scaffolding material, which exclude a wide range of cell-compatible 
scaffolding materials such as PLGA and collagen. For strategies that do not use hydrogel, 
throughput and cost are prohibitive for clinically-relevant applications [226]. Our strategy 
does not suffer from the shortcomings of the previous techniques and can be adopted for 
a wide range of tissue engineering applications where specific material properties are 
required as scaffolds.   
Our strategy offers several advantages compared to traditionally stacking or 
layering strategy to build 3D tissue engineering constructs. For example, Derda and 
colleagues built a 3D tissue engineered construct by assembling multiple layers of 
chromatography paper spotted with cell suspension [227]. While the authors 104 
 
demonstrated the biocompatibility of the paper as a scaffolding material that supported 
cell survival and growth, the paper itself cannot be degraded as an implantable material 
and is not FDA approved. While its wide commercial availability is certainly 
advantageous, it is disadvantageous from a material-processing perspective because it is 
pre-made, which makes it difficult to modify its material properties such as porosity and 
mechanical strength. In another study, Shimizu and colleagues stacked multiple layers of 
cardiomyocytes cultured separately to achieve a 3D tissue engineered construct [218]. 
Although this strategy also enabled investigators to create user-defined cell patterns in 3D, 
it significantly adds handling time and operator-variability compared to Tissue Origami 
strategy where the locations of patterns are mathematically defined in all three axes as a 
result of pre-determined folding lines specified in Miura-geometry.   
Angiogenesis is a complex process involving multiple cell types including ECs 
and VSMCs. Much of what we known currently about it came from the field of cancer 
biology where inhibition of this process may slow tumor growth and reduce the chance 
for metastasis [228]. In contrast, in tissue engineering, the challenge is to promote this 
process so that seeded cells in engineered scaffold have sufficient nutrients to survive. 
While it is commonly known that the EC and VSMC interacts with one another through 
cytokine signaling and physical contact [224], controlling angiogenesis is not a trivial 
pursuit for tissue engineering application due to the spatiotemporal requirements to 
regulate the complex process. A number of studies demonstrated a multi-cell type 
strategies can lead to improved formation of blood vessels in engineered scaffold [229-
231]. However, most of these studies did not provide any organizational cues in the 
scaffold and relied on seeded cells to self-assemble into blood vessels. Our findings that 105 
 
folded 3D constructs with homogeneously mixed populations of ECs and VSMCs 
showed significantly lower blood vessel formation than patterned EC and VSMC 
populations stamped on each facet suggest that spatially organizing populations of ECs 
and VSMCs may lead to higher blood vessel formation in the scaffold.     
In summary, we designed a new 3D cell patterning strategy based on folding 
thin, porous polymer films with Miura-geometry, built PLGA and collagen thin films 
with perforated folding lines that allows two distinct populations of cells to be 
simultaneously patterned in 3D and tested this strategy in building vascularized networks 
with ECs and VSMCs. We found that initial configuration that placed EC and VSMC 
populations on the same plane of each facet led to the greatest yield in terms of the blood 
vessel formation. This technique is particularly relevant to the field of tissue engineering 
where spatial organization of multiple cell populations can lead to improved tissue 
functions. The wide range of material compatibility, low cost and high-throughput 
enabled by method can facilitate its adoption in manufacturing of clinically-relevant sized 
tissue engineered construct.  
 
3.4  Experimental Challenges 
There were a number of challenges pertaining to the development of this method. 
The first challenge was to develop a foldable scaffold that is biocompatible and 
biodegradable. With solvent-casting method, we were able to obtain nonporous, thin 
PLGA films that permitted folding. However, we found that due to the elasticity of the 
film, the folded construct tended to unfold its 3D shape and revert back to an open film 
over time. In addition, we were concerned about the nutrient diffusion through the 106 
 
nonporous film to support cell survival and growth. To overcome these issues, we 
introduced an additional porogen-leaching step in the fabrication process and the 
resulting film became over 90% porous. The reduced density in the film greatly relieved 
the amount of mechanical stress experienced at the folding lines and the folded construct 
were able to remain in its folded shape indefinitely. The inter-connected porous structure 
also facilitates nutrient diffusion into the folded constructs. The folding process was later 
further improved with the incorporation of laser-etched perforated folding lines, which 
enhanced the accuracy and reproducibility of the manual folding.  
The second major challenge was to develop a method to pattern multiple cell 
populations on the thin film simultaneously in a high-throughput and low-cost manner. 
Since PLGA is relatively hydrophobic, our initial attempt to deposit cell suspensions 
proven to be difficult as the small volume of cell suspension droplet tended to adhere to 
the hydrophilic surface that is used to transfer the droplet (e.g. pipette tips) rather than the 
PLGA thin film. To overcome this challenge, we increased the viscosity of the cell 
suspension droplet by adding Matrigel to the media and constructed the post-stamping 
stamping system to facilitate the transfer of the droplet to the PLGA thin film. The 
droplets were pre-loaded onto the acrylic posts of the post-stamping systems, which are 
also hydrophobic. The droplets adhere to the post initially due to surface tension. 
However, when inverted and in contact with the PLGA surface, the droplets prefer the 
PLGA film than the posts and allowed the cell suspension to be stamped on the thin films. 
Since virtually any post- and cell-loading configurations can be designed in a CAD 
drawing, it enables any cell patterns to be created simultaneously in the thin films in a 
high-throughput and low cost manner. The patterning process was further improved with 107 
 
the assistance of laser-etched boundary to control the spreading of the deposited cell 
suspension in the thin film laterally.  
 
3.5  Materials and Methods 
3.5.1  Preparation and Fabrication of Thin Films and Bulk Scaffold 
3.5.1.1  PLGA Thin Film Fabrication 
Soda-lime glass plate (3” x 4” x 1/16”, Moliterno, Inc., Pepperell, MA) was 
rinsed in the order of acetone, propanol, ethanol, and methanol and blow-dried with 
nitrogen to clean the surface. Cleaned glass plate was immediately placed in a plasma 
generator (PlasmaPrep2, Gala Instrumente, Germany) and treated with ionized oxygen for 
30 seconds to render the surface hydrophilic. About 2 ml of 2% w/v alginate solution 
(Sigma-Aldrich, St. Louis, MO) was poured onto the center of the treated glass plate and 
spin-coated to achieve a uniform alginate thin coating. After drying the coating in an 
oven at 60°C for 30 minutes, glass slides (1” x 3”) were placed on the four edges of the 
alginate-coated glass plate to enclose an open square. The glass slides were clamped 
tightly onto the glass plate via 4 pairs of neodymium magnets (SuperMagnetMan, 
Birmingham, AL) to secure their formation. 20 µL of 1% w/v gelatin solution (Sigma-
Aldrich, St. Louis, MO) was pipetted uniformly along each of the four edges of the open 
square to seal any open gap between the glass slides and the glass plate. The construct 
was placed in a fridge at 4°C to solidify the gelatin solution until ready to use.  
Sugar (Domino Foods) particles were sieved between 90 to 106 µm. 1.2 g of 
sieved sugar particles was added to 1 mL of 10% w/v poly(lactic-co-glycolic) acid 
(PLGA, 75:25, Lakeshore Biomaterials, Birmingham, AL) in chloroform solution (Sigma, 108 
 
St. Louis, MO) to achieve a 9:1 (sugar:PLGA) weight ratio. Prior to casting the mixture, 
the alginate-coated glass construct was taken out of the fridge and allowed to warm up to 
room temperature for 15 minutes. After briefly swirling the mixture by hand, it was 
poured onto the center of the open square area of the glass construct. The mixture was 
allowed to dry for 30 minutes in the fume hood followed by an overnight desiccation step 
to fully evaporate any chloroform residue in the sugar/PLGA film. Finally, the entire 
construct was immersed in 4 L of DiH2O for 2 hours to leach out the sugar and to detach 
the film. The wet film was carefully placed on a Teflon net and allowed to dry for 4 hours 
in a 60°C oven.  
 
3.5.1.2  Collagen Thin Film Fabrication 
Glass plate (2” x 3” x 1/16”, VWR, Atlanta, GA) was rinsed in the order of 
acetone, propanol, ethanol, and methanol and blow-dried with nitrogen to clean the 
surface. 4 layers of Parafilm (VWR, Atlanta, GA) were wrapped near the edge of each 
side along the length of the plate to form a rectangular area with two open sides on the 
glass plate.  The glass/Parafilm constructs was stored until ready to use. 
2 g of collagen type I powder from bovine Achilles tendon (Sigma, St. Louis, 
MO) was added to 200 mL of 0.05 M glacial acetic acid (Sigma-Aldrich, St. Louis, MO) 
solution for 30 minutes. The mixture was blended in Oster blender at high setting for 8 
minutes to achieve an uniformly mixed collagen slurry. The slurry was de-foamed by 
centrifugation at 2000 RPM for 10 minutes at 4°C. Immediately after de-foaming, 3 g of 
collagen slurry was spread within the rectangular open area of the glass plate/Parafilm M 
(VWR, Atlanta, GA) construct and sandwiched with another clean glass plate of the same 109 
 
dimensions on top. The entire construct was clamped with 2 pairs of neodymium magnets 
(SuperMagnetMan, Birmingham, AL) to fasten the location of the glass slides and 
immediately placed horizontally in the freezer at -20°C for 24 hours to freeze the 
collagen slurry. The frozen collagen slurry construct was then transferred to a -80°C 
freezer for another 24 hours before finally lyophilized in a freeze-dryer (FTS System, 
Stone Ridge, NY) for 48 hours to obtain the collagen thin film.  
 
3.5.1.3  Bulk Scaffold Fabrication 
Similarly to the PLGA thin film, we fabricated the bulk PLGA scaffolds with a 
solvent casting and porogen leaching method. The casting volume was eight times higher 
than the thin film in order to keep the thickness of the bulk scaffold same as a 4-facet 
folded construct. We sieved sugar (Domino Foods) particles between 90 to 106 µm. 4.8 g 
of sieved sugar particles were added to 4 mL of 10% w/v PLGA (75:25, Lakeshore 
Biomaterials, Birmingham, AL) in chloroform (Sigma, St. Louis, MO) solution to 
achieve a 9:1 weight ratio. The mixture was swirled swiftly to homogenize the sugar 
particles and immediately casted into an alginate-coated well made from aluminum plate. 
After allowing the chloroform to evaporate and desiccate the construct overnight, the 
sugar was leached away in 4 L of DiH2O for 4 hours. The wet film was placed on a 
Teflon net and allowed to became fully dry at room temperature.  
To cut circular discs from the bulk scaffold sheet, we used the VersaLaser 
(VersaLaser VLS3.50, Scottsdale, AZ) set to 20% power and 80% speed with HPDFO 
lens. The diameter of the circular disc was 1 cm and we drew the shape in CorelDraw X5 110 
 
(Corel, Menlo Park, CA) and imported into the VersaLaser graphic user interface (GUI) 
software.  
 
3.5.2  Thin Film Characterization 
3.5.2.1  Film Thickness 
We measured the thickness of PLGA and collagen thin films via a digital caliper. 
To measure the average film thickness across the entire film, we folded the thin film two 
times to achieve a four layered construct and sandwiched the construct in-between two 
glass slides (1” x 3”, VWR, Atlanta, GA) before measurement. The glass slides served as 
spacers to evenly distribute the compressive force exerted by the digital caliper during the 
measurement. The average single film thickness was obtained by subtracting the 
thickness of the two glass slide spacers and then dividing by four.  
 
3.5.2.2  Collagen Thin Film Degradation  
12 circular pieces of collagen thin film with an approximate diameter of 9 mm 
were cut using a stopper hole borer (VWR, Atlanta, GA). The mass of each film was 
measured on a digital atomic scale and placed in a 12-well plate (BD Biosciences). 3 mL 
of collagenase solution at 0.1 mg/mL in PBS was added to each well and a small metal 
mesh weight was added on top to fully submerge the samples. At 0.5, 1, 1.5 and 2-hour 
time points, the enzymatic degradation was stopped by adding 2 mL of 10 mM 
phosphate-buffered EDTA solution (Invitrogen) to three of the 12 wells followed by DI 
water rinsing three times. The samples were then desiccated overnight at room 111 
 
temperature. The final mass of the dried samples were measured on the digital atomic 
scale to calculate the changes in mass due to degradation.  
  
3.5.3  Laser-etching and Folding of Thin Film 
Perforated lines in the shape of Miura-geometry were designed with CorelDraw 
X5 (Corel, Menlo Park, CA) and imported into VersaLaser GUI software. Laser 
(VersaLaser VLS3.50, Scottsdale, AZ) set to 10% power with 100% speed and HPDFO 
lens was sufficient to etch both PLGA and collagen thin sheet.  Prior to laser etching, the 
thin PLGA or collagen sheet was taped at the four corners in the center of a letter-sized 
plain paper to prevent any accidental movement during the etching process. After the thin 
PLGA or collagen sheet was etched with the designed Miura-geometry pattern, it was 
stored in large deep Petri dishes until ready to use.  
 
3.5.4  Post-stamping System Fabrication and Stamping 
The post-stamping system is composed of three parts: cylindrical acrylic posts, 
an acrylic base plate and an acrylic top plate. The dimensions of the acrylic posts were 
designed in CorelDraw X5 (Corel, Menlo Park, CA) and cut out with VersaLaser 
(VersaLaser VLS3.50, Scottsdale, AZ) with 90% power, 9% speed and HPDFO lens 
from an 12” × 12” × 1/8” acrylic plate (McMaster-Carr, Robbinsville, NJ). The diameter 
of the posts is 2 mm. After laser cutting, the posts remained loosely connected to the 
acrylic plate and could be easily removed by push gently with a pointed object such as a 
pair of tweezers. The top acrylic plate served as the base for posts attachment. The 
attachment locations were marked by gentle laser etching (50% power, 90% speed, 112 
 
HPDFO lens) with VersaLaser (VersaLaser VLS3.50, Scottsdale, AZ) such that the 
corresponding stamping locations align along the z-axis of a folded thin film with Miura-
geometry. The posts were individually glued to the marked locations with Epoxy 
(Permatex, Hartford, CT) and allowed to fully cure at room temperature for 4 hours. The 
bottom acrylic plate was consisted of two identical thin plates with dimensions 12” × 12” 
× 1/8” (McMaster-Carr, Robbinsville, NJ) glued together. The outer shape of the unfolded 
2D Miura-geometry was cut out in the center of one of the plates and served as a 
receiving base for the thin sheet. Finally, four screws were bored through at the four 
corners of the bottom plate with matching holes at the top plate to eliminate any 
movement laterally in the stamping process.  
Initial tests of post-stamping system with PLGA and collagen thin films were 
carried out with food colorings liquid droplets. For testing with PLGA thin films, we 
prepared diluted food coloring solutions by adding 5 drops of the concentrate 
(McCormick, Sparks, MD) to 10 mL of DiH2O. For collagen thin films, the food coloring 
solution was added to 1% w/v gelatin/DiH2O to increase the viscosity of the solution. The 
liquid droplets were pipetted onto each post on the top part of the post-stamping system 
and gently inverted and lowered onto the thin film that sit at the well at bottom part of the 
post-stamping system. The four nuts were threaded on the screw to prevent any vertical 
movement. The top part was lifted slowly after 1 minute of contact and inspected for any 
residue droplet.  
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3.5.5  Cell Culture 
Human umbilical vein endothelial cells (HUVECs) (Lonza, Walkersville, MD) 
at passage 3 were cultured in EGM-2 media (Lonza, Walkersville, MD) in a water-
jacketed 5% CO2 incubator at 37°C. Following initial seeding, the cells were fed every 
other day until reaching 80-90% confluence, at which point, the cells were passaged and 
re-seeded at a density of 5000 cells/cm2. All experiments were performed at passage 5-6. 
Human aortic smooth muscle cells (HASMCs) (Lonza, Walkersville, MD) at 
passage 3 were cultured in SmGM-2 media (Lonza, Walkersville, MD) in a water-
jacketed 5% CO2 incubator at 37°C. Following initial seeding, the cells were fed every 
other day until reaching 60-70% confluence, at which point, the cells were passaged and 
re-seeded at a density of 10000 cells/cm2. All experiments were performed at passage 5-6. 
Whenever a mix population of both HUVECs and HASMCs were co-cultured in 
the folded or bulk construct, a mixed media consisted of 3 parts SmGM-2 and 1 part 
EBM-2 were used [232]. The media was changed every day until ready for in vivo 
implantation or in vitro assay.  
 
3.5.6  Cell Patterning of Thin Film with Post-stamping System 
Top and bottom parts of the post-stamping system were sterilized by spraying 
thoroughly with 70% v/v ethanol/DiH2O followed by ultraviolet (UV) sterilization for 30 
minutes in the biosafety cabinet. The perforated PLGA and collagen thin films were 
sterilized by UV sterilization for 1 hour on each side in the biosafety cabinet. Light 
neodymium magnetic rings (Model: R1013D, SuperMagnetMan, Birmingham, AL) were 
wrapped with Teflon tape and sterilized with sonication in 70% v/v ethanol/DiH2O 114 
 
solution for 15 minutes in a water-bath sonicator. The magnetic rings were air dried for 
30 minutes within the biosafety cabinet and stored in a sterile Petri dish prior to cell 
patterning. All tweezers used for handling the thin film and the scaffold were sterilized in 
an autoclave.  
Matrigel (BD Biosciences) was thawed in 4°C fridge overnight prior to the day 
of cell patterning. On the day of patterning, HUVECs or HASMCs in tissue culture flask 
were detached with 2 mL of 0.25% trypsin for 4 minutes at 37°C. The trypsinization 
reaction was stopped by adding 5 mL of the corresponding culture media and 
subsequently centrifuged at 2200 RPM for 5 minutes at 4°C. The supernatant was 
discarded and the cell pellet was suspended in a cold 50% v/v media/Matrigel solution at 
a density of 1 x 108 cells/mL. The cell suspension was pipetted rapidly to uniformly 
disperse the cell pellet and kept ice until use. A mixed population of HUVECs and 
HASMCs was prepared by pipetting equal volumes of cell suspension from each 
individual cell suspension and mixed thoroughly with a pipette.  
Sterilized PLGA or collagen thin film was placed within the receiving base of 
the bottom part of the post-stamping system. 3 µL cell suspension of interest were 
deposited onto the posts by pipetting manually to achieve the desired cellular 
arrangement. Cell suspension was mixed by pipetting every 5 transfers to ensure an even 
amount of cells deposited on each post. When all posts were loaded with cell suspensions, 
the posts were inverted and put in contact with the thin film. Four nuts were threaded on 
the screws to prevent any vertical movement. The top part was lifted slowly after 1 
minute of contact and inspected for cell suspension residues. The thin film was removed 
carefully from the well with sterile tweezers and folded following the creased lines into 115 
 
the 3D Miura-geometry. The folded construct was clamped with a pair of Teflon tape 
wrapped magnetic rings to prevent the construct from unfolding and placed in a 12 well 
plate at 4°C. After completing all folded constructs, the 12-well plate was incubated in a 
water-jacketed 5% CO2 incubator at 37°C for 10 minutes without media to polymerize 
the Matrigel and encapsulate the patterned cells at their stamping locations. Subsequently, 
3 mL of 37°C media corresponding to the patterned cell populations was added to each 
well to fully immerse the construct. Due to the weight of the magnetic rings, the cell-
bearing construct stayed immersed within the media. The constructs were cultured until 
ready for in vivo implantation or in vitro assay.  
 
3.5.7  Immunohistochemistry 
3.5.7.1  Cell Membrane Labeling 
To label cell of interest with DiI or DiO membrane dye prior to stamping, cells 
were suspended at 1 x 106 cells/mL in serum-free culture media (EBM-2 for EC or 
SmBM basal medium for VSMC, Lonza, Walkersville, MD). 5 µL of cell-labeling 
solution (Vybrant Multicolor Cell-Labeling Kit, Invitrogen) per mL of cell suspension 
was added to the cell suspension and mixed by gently pipetting. The cell suspensions was 
then incubated in the water-jacketed 5% CO2 incubator at 37°C for 20 minutes followed 
by centrifuge at 1500 RPM for 5 minutes at room temperature. The supernatant was 
carefully removed and the cells were then re-suspended at 1 x 106 cells/mL in their 
corresponding media at 37°C. The cells were washed three times by centrifuging at 1500 
RPM for 5 minutes followed by removing the supernatant. The cell suspension was then 
stored on ice bath until ready to use.  116 
 
 
3.5.7.2  Immunohistochemistry Paraffin Staining on Sectioned Slides 
Paraffin-embedded sectioned slice of explanted scaffold were stained for ECs 
and VSMCs. The 5 µL sectioned slices were deparaffinized by sequentially immersed in 
xylene (Sigma, St. Louis, MO, xylene, ethanol, ethanol, 95% ethanol, 95% ethanol, 70% 
ethanol, 50% ethanol, DiH2O, DiH2O, and Tris-buffered saline (TBS, Cellgro, Radnor, 
PA) for 2 minutes each. Prior to antibody staining, antigen retrieval is performed by 
immersing the deparaffinized slides in Tris-EDTA buffer (10 mM Tris, 1 mM EDTA, 
0.05% Tween 20 adjusted to pH 9.0) at 95°C for 30 minutes. After allowing the slides to 
cool down to room temperature, the slides were blocked with 5% goat serum in TBS for 
1 hour at room temperature followed by incubation with a rabbit anti-human caldesmon 
primary antibody (ab45691, 1:100 dilution, Abcam, Cambridge, MA) in 5% goat serum 
overnight at 4°C. On the following day, the slides were washed for three times in TBS for 
5 minutes each and stained with a goat anti-rabbit Texas Red secondary antibody (ab6719, 
1:100 dilutions, Abcam, Cambridge, MA) in 5% goat serum for 40 minutes at room 
temperature. After washing the slides for three times in TBS for 5 minutes each, the 
slides were blocked with 5% donkey serum in TBS for 1 hour and subsequently 
incubated overnight with a sheep anti-human CD31 primary antibody (af806, 1:30 
dilutions, R&D Systems, Minneapolis, MN) at 4°C in 5% donkey serum. The slides were 
washed for three times in TBS for 5 minutes each at room temperature on the following 
day and stained with a donkey anti-sheep FITC secondary antibody (ab97124, 1:100 
dilutions, Abcam, Cambridge, MA) in 5% donkey serum for 40 minutes at room 
temperature. Finally, the slides were rinsed for three times in TBS for 5 minutes each and 117 
 
mounted on glass slides using Prolong Gold antifade reagent with DAPI (Invitrogen) and 
stored in -20°C freezer until confocal imaging. All incubations steps were carried out in a 
humidified chamber to prevent slide from drying out.  
 
3.5.8  Scanning Electron Microscopy 
Field emission scanning electron microscopy (FESEM, Zeiss Ultra 55, 
Thornwood, NY) images of the PLGA and collagen thin films were taken to visualize the 
porous structure within the film. Prior to SEM, PLGA or collagen samples near the center 
of the film was cut out and coated with Pt/Pd for 90 seconds at 40 mA with a sputter 
coater (208HR, Cressington Scientific Instruments, UK). Samples were imaged using 
SEM at a beam voltage of 5 kV.  
 
3.5.9  Confocal Microscopy 
3.5.9.1  Z-stack Imaging of Whole-mount Folded Construct 
Patterned cells labeled with DiI and DiO in folded Miura-geometry construct 
were fixed in 4% paraformaldehyde for 15 minutes and stained in situ with DAPI nucleus 
stain for 5 minutes at room temperature. The construct was washed in PBS for three times 
at 5 minutes each and placed in a glass bottom Petri dish (MatTek Corporation, Ashland, 
MA) with PBS. Prior to Z-stack confocal imaging, the construct was weighed down with 
a 22 mm coverslip on top of the construct to prevent any accidental movement and to 
ensure a good contact with the bottom glass. 20 z-stack slices spanning 140 µm were 
scanned sequentially (Carl Zeiss LSM 510 inverted confocal microscope, Thornwood, 
NY) with a C-Apochromat 40x/1.2 W lens at 1x zoom and laser wavelengths at 405, 484 118 
 
and 549 nm for DAPI, DiO and DiI staining, respectively. 3D renderings of cell 
distribution were reconstructed using the Zen 2011 software.  
 
3.5.9.2  Grid Imaging of Sectioned Slide from in vivo Explants 
36 fields of view consisted of 6 rows labeled 1 to 6 and 6 columns labeled A to 
F were imaged systemically for each deparaffinized stained slide using the grid-imaging 
tool in Zen 2011 image acquisition software (Carl Zeiss LSM 510 inverted confocal 
microscope, Thornwood, NY). For each sectioned construct, the four corners representing 
the maximum and minimum coordinates in the x- and y-axis were set as the four corner 
images for the grid (1A, 1F, 6A and 6F). DAPI, FITC and Texas Red stains were 
sequentially excited with 405 nm, 488 nm and 633 nm lasers respectively and imaged for 
each grid (Carl Zeiss LSM 510 inverted confocal microscope, Thornwood, NY).  
 
3.5.10  Cell Viability and Metabolic Assays 
The viability of cells encapsulated in polymerized Matrigel (BD Biosciences) in 
folded PLGA construct was examined by a Live/Dead (viability/cytotoxicity) assay for 
mammalian cells (Molecular Probes, Eugene, OR).  Two hours after initial seeding, 
folded construct was washed gently with Dulbecco's phosphate-buffered saline (D-PBS, 
Invitrogen) and incubated with 2 µM calcein-AM and 4 µM ethidium homodimer-1 
(Molecular Probes, Eugene, OR) for 45 minutes at room temperature before imaged with 
a Zeiss Axiovert 200 M fluorescence microscope (Carl Zeiss Micro-Imaging, 
Thornwood, NY) with GFP and Texas Red channels.  119 
 
To quantitatively assess the metabolic activities of seeded cells in folded or bulk 
PLGA construct after an extended period of culture, alamarBlue cell viability assay 
(Invitrogen) was used. After 3 days of culture in a 12-well plate with media change every 
day, folded or bulk construct was washed gently with D-PBS and then replenished with 2 
mL of fresh culture media. Prior to adding alamarBlue solution, the constructs were cut 
into small pieces with sterile surgical scissors within the well to increase the surface area 
to volume ratio. After 200 µL of alamarBlue solution was added to each well, the plate 
was gently swirled until the alamarBlue solution became uniformly mixed with the media. 
The plate was then incubated for 1 hour in a water-jacketed 5% CO2 incubator. After 
gently pipetting each well up and down a few times to mix the solution, three 100 µL 
solution of each condition were added to a 96-well plate and its fluorescence was read 
using a fluorescence excitation wavelength of 570 nm and emission wavelength of 585 
nm (Gemini XPS fluorescence microplate reader, Molecular Devices, Sunnyvale, CA). 
We used an acellular PLGA scaffold as negative control and subtracted its fluorescent 
readings as background from other conditions.  
 
3.5.11  in vivo Mouse Implantation of Scaffold and Harvest 
All animal experiment was approved by the Standing Committee on the Use of 
Animal in Research and Teaching at the Faculty of Arts and Sciences at Harvard 
University. Male C.B.-17 SCID/beige mice between 5-8 weeks (Taconic Farms, 
Germantown, NY) were anesthetized by 2% isofluorane in 98% O2 via inhalation using a 
nose cone on a water-heated surgical platform. After shaving the dorsal trunk and 
preparing the skin for surgery, one 1 cm incision pocket was made on each side of the 120 
 
dorsum and a subcutaneous pocket was created for scaffold implantation. Each mouse 
received a combination of a bulk and a Miura-folded scaffold or two pairs of Miura-
folded scaffold of different seeding configurations. Incisions was sutured (3-4 sutures per 
incision) with polypropylene monofilament suture (PROLENE, Ethicon, Somerville, NJ). 
Subcutaneous injections of buprenorphine (American Regent Inc., Shirley, NY) were 
given to all mice every 12 hours for 72 hours as analgesia. Up to 4 mice was placed in an 
individual cage until harvest two weeks later from the initial surgery date.  
On day 14 since initial surgery, the mice were euthanized and incisions were 
made with surgical scissors around the subcutaneous pockets to harvest the implanted 
construct. Roughly a 1 cm2 skin section was removed and fixed in 4% paraformaldehyde 
overnight. On the following day, the fixed tissues were transferred to 70% ethanol 
solution and shipped to Mass Histology Service (Worcester, MA) for paraffin embedding 
and sectioning.  
 
3.5.12  Vessel Density Calculation 
Blood vessels in confocal images were identified by anti-human CD31 and anti-
human Caldesmon immunofluorescent staining. For each sectioned slice of the explanted 
construct, the number of human Caldesmon positive blood vessels was manually counted 
from the 36 field of views designated from 1A to 6F. The total blood vessel number were 
averaged with the two other constructs and divided by the total area of the field of view 
to obtain the vessel density. All results were compared using ANOVA on rank tests, with 
pairwise comparison performed using the Tukey’s test.  
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4  Conclusion 
Vascular tissue functions are fundamentally linked to its structural organization 
across multiple spatial scales. At the tissue level, endothelial cells line the inner most 
layer of the blood vessel to protect the VSM from blood shearing force while VSM wraps 
around the ECs in helices in order to withstand the expansion force both longitudinally 
and laterally. At the cellular level, VSMCs assume an elongated spindle-shape and 
connect with either other cells or the ECM in order to efficiently propagate mechanical 
forces along the blood vessel wall. At the subcellular level, cytoskeletal architecture can 
influence a wide array of VSM functions including proliferation, migration and 
contraction. When this elegant structure-function relationship in vascular tissue is 
disrupted in pathological conditions, maladaptive remodeling in the tissue structure can 
lead to diseased functional outcomes in vitro. While it is difficult to pinpoint the exact 
cause that initiated the structure remodeling in vitro due to the complex native signal and 
tissue interactions, a highly controllable artificial cellular microenvironment can be 
engineered in vitro to regulate the tissue structure and in turn, tissue functions. With the 
integration of increasingly precise microfabrication technologies in tissue engineering, an 
engineering algorithm based on designing and building vascular architecture to achieve 
desired functional outcomes has emerged. For example, our group has previously applied 
this algorithm in a proof-of-concept study and successfully reverse engineered a Aurelia 
aurita jellyfish in a biohybrid life form consisted of synthetic polymer thin film and 
spatially engineered rat cardiac tissue [233]. With this dissertation, we developed in vitro 
models to understand how cellular shape of VSMC as a structural input can affect its 
contractile strength and cytoskeletal arrangement and how engineered spatial 122 
 
organizations of ECs and SMCs in a three-dimensional polymer matrices can affect 
vascularization.  
 
4.1  The Effect of Vascular Smooth Muscle Cell Shape on Cytoskeletal 
Architecture and Contractile Strength 
Although structure and function are closely coupled in the vascular tissues as 
described above, their relationship can vary depending on the location in which they were 
found. For example, it has been observed that VSMC shape and function are uniquely 
defined by the locations in the cardiovascular system. In large diameter elastic arteries, 
exemplified by the aorta, VSMC has a length to width aspect ratio of about 10:1. 
However, in mid-sized muscular arteries, such as the external carotid artery of the neck 
and femoral artery of the thighs, the VSMC AR increased to 15:1. Functionally, VSMC 
in elastic arteries contract to maintain vessel pressure during the cardiac cycle whereas 
VSMC in muscular arteries regulate blood flow and pressure by constricting or relaxing 
the vessel wall. While it has been speculated that the elongated cellular shape for VSMC 
in elastic arteries may provide better dynamic response to blood pressure and pressure 
changes, its primary function, there is no definitive evidence to support this structure-
function relationship.  
In chapter 2, we investigated the how the contractile strength and cytoskeletal 
architecture of VSMC changes as a function of its cellular shape. We developed an in 
vitro model by engineering human VSMCs to take on the same shapes as those seen in 
elastic and muscular arteries and measured their contraction during stimulation with 
endothelin-1. We measured the actin alignment and nuclear eccentricity of engineered 123 
 
VSMCs and found that they increased as the shape of the cell elongated. Using traction 
force microscopy, we measured the contractile strength of individual VSMCs and found 
VSMCs with elongated shapes exhibited lower contractile strength but greater percentage 
increase in contraction after endothelin-1 stimulation. We analysed the relationship 
between smooth muscle contractility and subcellular architecture and found that changes 
in contractility were correlated with actin alignment and nuclear shape. These results 
suggest that elongated VSMC shape facilitate muscular artery tone modulation by 
increasing its dynamic contractile range, suggesting that where the vasculature requires a 
higher fidelity in its modulation of blood flow, longer, thinner cells are functionally 
advantageous.  
This study highlighted the advantage of the design, build and test engineering 
algorithm for in vitro systems where we can precisely design the cellular 
microenvironment, build the cell or tissue of interest and test exactly how an independent 
input, the cell shape, can affect a dependent output, the contractile strength. In addition, 
this result here is particularly relevant for the tissue engineering of small-diameter vessel 
graft where functional mismatch between host and graft has been a major challenge in the 
past two decades. Our findings suggest that in addition to mimicking the biomechanical 
aspect of the healthy artery, providing guidance cues to engineer the VSMCs into the 
desired shape may improve the functionality and long-term patency of vascular graft.  
 
4.2  Engineering Vascularized Network in Folded, Porous Polymer Matrices by 
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At the tissue level, design considerations for engineering vascular tissues 
broaden to include the spatial interaction and assembly between multiple cell types. 
However, these factors are often neglected in conventional tissue design dogma where 
multiple cell types are simply mixed and directly placed on the supporting polymer 
matrices, without controlling for their three-dimensional structural organization. As a 
result, the engineered tissue construct often has little organization to its architecture. In 
contrast, tissues in vitro consist of hierarchical smaller repeating unit on the scale of 
hundreds of microns that interacts with neighboring cells and performance specific 
functions. This difference in microarchitecture leads to suboptimal functions for tissue 
engineered construct and hindered the advancement of this field in achieving clinically 
relevant organ replacement products.  
In chapter 3, we developed a novel 3-dimensional cell patterning method based 
on folding of polymer thin film to spatially organize cellular interactions. We fabricated 
porous, foldable thin films from synthetic (PLGA) and natural (collagen) polymers and 
laser-etched perforated lines in them to facilitate the folding process. We built a simple 
acrylic stamping system that utilizes small posts to deposit liquid cell suspensions at user-
defined locations on the 2-dimensional thin film. The 3-dimensional tissue construct with 
spatially defined cellular interactions was obtained by folding the cell-patterned thin film 
into a Miura-ori geometry and cultured. We evaluated the viability of cells in folded 
construct and found they remain alive after 72 hours. We applied this method in a proof-
of-concept study to build a vascularized tissue with different EC and VSMC spatial 
configurations in a subcutaneous immunodeficient mouse in vitro model. We found that 
folded scaffold with EC and SMC patterned laterally on the same plane produced a 125 
 
significantly higher number of vessels compared to folded configuration where EC and 
SMC were seeded in a homogeneous mixture.  
Prior to the development of this method, organization of spatial cellular 
interactions in 3-dimensionl synthetic and natural polymer scaffold remains a challenge. 
The fact that this method is compatible with both synthetic and natural polymers makes it 
widely applicable to many fields of tissue engineering in which these types of polymers 
were frequently used as scaffolding materials for cells. In addition, with the field of tissue 
engineering moving towards co-culture of multiple cell types, the ability to spatially 
organize their interactions in 3-dimensional scaffold can be a valuable tool. With our 
proof-of-concept study in building vascularized tissue with patterned ECs and SMCs, our 
findings suggested that increasing spatially organized interactions between ECs and 
SMCs may lead to a more efficient vascularization in a porous synthetic scaffold than 
simply mixing the two cell types homogeneously. This is particularly relevant for 
engineering thicker or more metabolically demanding tissue replacement where more 
efficient vascularization may improve overall tissue survival and function.   
 
4.3  Limitations and Future Directions 
With this dissertation, we elucidated how structure cues such as cell shape and 
spatial interactions between multiple cell types can affect the functions of cells and 
tissues. One of the drawbacks for our study in chapter 2 is the use of isolated VSMCs, 
which lacks physiological relevance compared to confluent VSMC tissue in vitro. In a 
previous study where we investigated the contractility of patterned VSM tissue, the 
cellular shapes assume a range of length to width ratios in VSM tissues. Therefore, there 126 
 
is a tradeoff between in vitro relevancy and the precision in control over the 
microenvironment. A possible solution to this challenge may be to grow VSMCs on 
close-packed micropatterned ECM protein islands such that individual VSMC shapes can 
be controlled while allowing neighboring VSMCs to communicate with each other. This 
may lead to more physiologically relevant in vitro VSM tissue model and bring us closer 
to achieving an engineered functional VSM tissue.  
One limitation of our 3D cell patterning strategy in chapter 3 is the need for 
Matrigel for seeding the cells on the polymer thin films. The Matrigel encapsulates the 
patterned cells on the thin film when polymerized, allowing us to control the spatial cell 
distribution in 3D. Since Matrigel is a protein mixture secreted by the Engelbreth-Holm-
Swarm mouse sarcoma cells, it may contain growth factors or cytokines that signals non-
physiological behavior on human cells. This poses significant concern for using this 
strategy in a clinical setting. Therefore, future studies should test for replacement 
hydrogel material that allows cell encapsulation, yet do not contain the mixture of 
cytokines.   
 
4.4  Dissertation Summary 
Collectively, the work in this dissertation provided new insights into the effect 
of cell shape and tissue spatial organizations on the functions of engineered vascular 
tissues. In chapter 1, we first presented an engineering algorithm that is broadly 
applicable for building biological tissues. We used vascular smooth muscle tissue as an 
example and elucidated how we can engineer a functional VSM in vitro by designing the 
cellular architecture with mechanotransductive cytoskeletal proteins, building it with 127 
 
engineered mechanical cues in the cellular microenvironment, and finally testing the 
performance of the engineered cells with a functional metrics. We applied this 
engineering algorithm in chapter 2 by designing and building human vascular smooth 
muscle cells to take on the same shapes as those seen in elastic and muscular arteries in 
vitro and subsequently measuring their contraction during stimulation with endothelin-1 
with traction force microscopy as a function of cellular shape. We found the actin 
alignment and nuclear eccentricity of engineered VSMCs increased as the shape of the 
cell elongated. We found VSMCs with elongated shapes exhibited lower contractile 
strength but greater percentage increase in contraction after endothelin-1 stimulation, 
suggesting elongated VSMC shape enables muscular artery to have greater dynamic 
contractile range. In chapter 3, we developed a 3-dimensional cellular patterning strategy 
based on folding of polymer thin films and measured the effect of spatial interactions 
between ECs and SMCs in forming a vascularized network in folded, porous polymer 
matrices. We folded PLGA and collagen thin films along laser-etched perforated lines 
and patterned the thin films by stamping cell suspensions on them with a post-stamping 
system. We evaluated the cell survival in folded construct and found cells were viable 
after 72 hours post stamping. We used an subcutaneous implantation mouse model to 
evaluate vascularization efficiency and found that three-dimensional organization that 
patterned human ECs and SMCs within the same folding facet had significantly higher 
density of human caldesmon positive blood vessels than folded construct patterned with a 
homogenously mixed populations of ECs and SMCs, suggesting that increasing spatially 
organized interactions between EC and SMC may lead to more densely vascularized 
tissues.  128 
 
In summary, this dissertation enhanced our understanding for the design and 
assembly of engineered vascular tissues. We learned that structure and functions are 
closely coupled in vascular systems across multiple spatial scales and as bioengineers, we 
can harness this structure-function relationship by engineering cellular and tissue 
microenvironment to build specific cellular and tissue architecture that give rises to 
desired functions in vitro.      
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6.2  Appendix B: MATLAB code for analyzing cellular forces in traction force 
microscopy studies 
function DBG_force_calculation(pathname) 
cd(pathname); 
  
imgfile = ('Full_stack_aligned.tif'); 
tif_info = imfinfo(imgfile); 
tif_size = size(tif_info,1); 
file_name = ['Full_stack_aligned_ROI_1_1_512_512_1_' num2str(tif_size) 
'_Mat.mat']; 
load (file_name); 
load ('ROI_1_1_512_512_Cell_boundary.mat'); 
frame_count = length(TFM_results); 
  
I = imread('Cell.tif'); 
c = xrub; 
r = yrub; 
BW = roipoly(I,c,r); 
scaled_mask=imresize(BW,1/16,'nearest'); 
sum_force = zeros(10,2); 
for frame_number = 1:frame_count 
     
%for the first frame, get the principle and normal axis of the cell 150 
 
if frame_number == 1 
figure, imshow('Cell.tif'); 
h = imline; 
position = wait(h); 
principle_axis = [position(2,1)-position(1,1), position(2,2)-position(1,2)]; 
% get unit vector 
principle_axis = principle_axis / norm(principle_axis); 
normal_axis = [-(position(2,2)-position(1,2)), position(2,1)-position(1,1)]; 
normal_axis = normal_axis / norm(normal_axis);  
close all 
end 
  
  
%getting the principle axis traction force 
tract_parallel = zeros(length(TFM_results(1,1).traction(:,:)),1); 
for i = 1:length(TFM_results(1,frame_number).traction(:,:)) 
    tract_parallel(i) = 
abs(dot(principle_axis,TFM_results(1,frame_number).traction(i,:))); 
end 
  
%convert to a 32 x 32 grid 
tract_parallel_array = zeros(32); 
count = 1; 151 
 
for i = 1:32 
    for k = 1:32 
        tract_parallel_array(k,i) = tract_parallel(count); 
        count=count+1; 
    end 
end 
  
tract_parallel_array_mask = tract_parallel_array.*scaled_mask; 
sum_force_principle = sum(sum(tract_parallel_array_mask)); 
  
%getting the perpendicular axis traction force 
tract_perpendicular = zeros(length(TFM_results(1,1).traction(:,:)),1); 
for i = 1:length(TFM_results(1,frame_number).traction(:,:)) 
    tract_perpendicular(i) = 
abs(dot(normal_axis,TFM_results(1,frame_number).traction(i,:))); 
end 
  
%convert to a 32 x 32 grid 
tract_perpendicular_array = zeros(32); 
count = 1; 
for i = 1:32 
    for k = 1:32 
        tract_perpendicular_array(k,i) = tract_perpendicular(count); 152 
 
        count=count+1; 
    end 
end 
  
tract_perpendicular_array_mask = tract_perpendicular_array.*scaled_mask; 
sum_force_perpendicular = sum(sum(tract_perpendicular_array_mask)); 
  
%convert from Pa to uN by multiplying 100um^2 lattice area and then divide 
%by 2 since two ends 
sum_force(frame_number,:) = [sum_force_principle 
sum_force_perpendicular]/10000/2; 
end 
%save the file 
[nrows,ncols]= size(sum_force); 
filename = 'sum_force.txt'; 
fid = fopen(filename, 'w'); 
for row=1:nrows 
    fprintf(fid, '%6.4f %6.4f\r\n', sum_force(row,:)); 
end 
fclose(fid); 
load sum_force.txt; 
xlswrite('sum_force.xls', sum_force); 
  153 
 
function [initial, ET_1, HA, ref] = DBG_calculate_average_X(pathname) 
cd(pathname); 
  
imgfile = ('Full_stack_aligned.tif'); 
tif_info = imfinfo(imgfile); 
tif_size = size(tif_info,1); 
  
num = xlsread('sum_force.xls'); 
  
if (tif_size < 11) 
    initial = 0; 
    ET_1 = 0; 
    HA = 0; 
    ref = 0; 
else 
    initial = mean(num(1:3,1)); 
    ET_1 = mean(num(4:6,1)); 
    HA = mean(num(7:9,1)); 
    ref = num(10,1); 
end 
end 
 
function [initial, ET_1, HA, ref] = DBG_calculate_average_Y(pathname) 154 
 
cd(pathname); 
  
imgfile = ('Full_stack_aligned.tif'); 
tif_info = imfinfo(imgfile); 
tif_size = size(tif_info,1); 
  
num = xlsread('sum_force.xls'); 
  
if (tif_size < 11) 
    initial = 0; 
    ET_1 = 0; 
    HA = 0; 
    ref = 0; 
else 
    initial = mean(num(1:3,2)); 
    ET_1 = mean(num(4:6,2)); 
    HA = mean(num(7:9,2)); 
    ref = num(10,2); 
  
end 
end 
 